<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Behav. Neurosci.</journal-id>
<journal-title>Frontiers in Behavioral Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Behav. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5153</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnbeh.2017.00119</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson&#x02019;s Disease Differently Affects Behavior</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Antipova</surname> <given-names>Veronica A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/436540/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Holzmann</surname> <given-names>Carsten</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/412945/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Schmitt</surname> <given-names>Oliver</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/49008/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wree</surname> <given-names>Andreas</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/72457/overview"/>
</contrib> 
<contrib contrib-type="author">
<name><surname>Hawlitschka</surname> <given-names>Alexander</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Institute of Anatomy, Rostock University Medical Center</institution> <country>Rostock, Germany</country></aff>
<aff id="aff2"><sup>2</sup><institution>Institute of Macroscopic and Clinical Anatomy, Medical University of Graz</institution> <country>Graz, Austria</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Medical Genetics, Rostock University Medical Center</institution> <country>Rostock, Germany</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Nuno Sousa, Instituto de Pesquisa em Ci&#x000EA;ncias da Vida e da Sa&#x000FA;de (ICVS), Portugal</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Carlos Tomaz, University CEUMA, Brazil; Salim Yalcin Inan, University of Konya-NE, Turkey</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Andreas Wree <email>andreas.wree@med.uni-rostock.de</email></p></fn>
<fn fn-type="other" id="fn002"><p><sup>&#x02020;</sup>These authors have contributed equally to this work.</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>21</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>11</volume>
<elocation-id>119</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>02</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>06</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Antipova, Holzmann, Schmitt, Wree and Hawlitschka.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Antipova, Holzmann, Schmitt, Wree and Hawlitschka</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract><p>Parkinson&#x02019;s disease (PD) is one of the most frequent neurodegenerative disorders. The loss of dopaminergic neurons in the substantia nigra leads to a disinhibition of cholinergic interneurons in the striatum. Pharmacotherapeutical strategies of PD-related hypercholinism have numerous adverse side effects. We previously showed that ipsilateral intrastriatal injections of 1 ng in unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rats inhibit apomorphine-induced rotation behavior significantly up to 6 months. In this study, we extended the behavioral testing of ipsilateral botulinum neurotoxin A (BoNT-A)-injection and additionally investigated the impact of intrastriatal BoNT-A-injections contralateral to the 6-OHDA-lesioned hemisphere on the basal ganglia circuity and motor functions. We hypothesized that the interhemispheric differences of acetylcholine (ACh) concentration seen in unilateral hemi-PD should be differentially and temporally influenced by the ipsilateral or contralateral injection of BoNT-A. Hemi-PD rats were injected with 1 ng BoNT-A or vehicle substance into either the ipsilateral or contralateral striatum 6 weeks after 6-OHDA-lesion and various behaviors were tested. In hemi-PD rats intrastriatal ipsilateral BoNT-A-injections significantly reduced apomorphine-induced rotations and increased amphetamine-induced rotations, but showed no significant improvement of forelimb usage and akinesia, lateralized sensorimotor integration and also no effect on spontaneous locomotor activity. However, intrastriatal BoNT-A-injections contralateral to the lesion led to a significant increase of the apomorphine-induced turning rate only 2 weeks after the treatment. The apomorphine-induced rotation rate decreases thereafter to a value below the initial rotation rate. Amphetamine-induced rotations were not significantly changed after BoNT-A-application in comparison to sham-treated animals. Forelimb usage was temporally improved by contralateral BoNT-A-injection at 2 weeks after BoNT-A. Akinesia and lateralized sensorimotor integration were also improved, but contralateral BoNT-A-injection had no significant effect on spontaneous locomotor activity. These long-ranging and different effects suggest that intrastriatally applied BoNT-A acts not only as an inhibitor of ACh release but also has long-lasting impact on transmitter expression and thereby on the basal ganglia circuitry. Evaluation of changes of transmitter receptors is subject of ongoing studies of our group.</p></abstract>
<kwd-group>
<kwd>botulinum toxins</kwd>
<kwd>hemiparkinsonism</kwd>
<kwd>behavior</kwd>
<kwd>Wistar rats</kwd>
<kwd>striatum</kwd>
</kwd-group>
<counts>
<fig-count count="8"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="161"/>
<page-count count="17"/>
<word-count count="13369"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>Parkinson&#x02019;s disease (PD) is one of the most prevalent debilitating chronic progressive neurodegenerative movement disorders and mainly caused by degeneration of dopaminergic neurons especially in the substantia nigra pars compacta (SNC; Hornykiewicz and Kish, <xref ref-type="bibr" rid="B67">1987</xref>; Braak et al., <xref ref-type="bibr" rid="B17">2004</xref>). This results in a deficit of striatal dopamine (DA) that leads to the impairment in cortico-striatal-thalamo-cortical or nigrostriatal pathways (Bagga et al., <xref ref-type="bibr" rid="B7">2016</xref>; Inan et al., <xref ref-type="bibr" rid="B70">2016</xref>; Kim et al., <xref ref-type="bibr" rid="B76">2016</xref>) and is responsible for the major motor symptoms of PD, including muscular rigidity, resting tremor, bradykinesia and postural instability (Dauer and Przedborski, <xref ref-type="bibr" rid="B35">2003</xref>; Kortekaas et al., <xref ref-type="bibr" rid="B81">2005</xref>; Ren et al., <xref ref-type="bibr" rid="B115">2016</xref>), and non-motor disturbances (Bargiotas and Konitsiotis, <xref ref-type="bibr" rid="B80">2013</xref>).</p>
<p>In the striatum the decrease of DA is followed by an increase in the concentration of acetylcholine (ACh) released from disinhibited tonically active cholinergic striatal interneurons (Gerfen, <xref ref-type="bibr" rid="B60">1994</xref>; Day et al., <xref ref-type="bibr" rid="B36">2006</xref>; Pisani et al., <xref ref-type="bibr" rid="B109">2007</xref>; Obeso et al., <xref ref-type="bibr" rid="B101">2008b</xref>). Therefore, one possible therapeutic approach in PD is using anti-cholinergic drugs (Klockgether, <xref ref-type="bibr" rid="B78">2003</xref>; Horstink et al., <xref ref-type="bibr" rid="B68">2006</xref>). However, systemic application of anti-cholinergics has some peripheral and central side effects (Clarke, <xref ref-type="bibr" rid="B28">2002</xref>; Fernandez, <xref ref-type="bibr" rid="B52">2012</xref>; Connolly and Lang, <xref ref-type="bibr" rid="B30">2014</xref>). To avoid these undesirable effects connected with systematic administration of anti-cholinergic drugs, we tested a local anti-cholinergic treatment by injecting botulinum neurotoxin A (BoNT-A) directly into the caudate putamen (CPu; Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>; Holzmann et al., <xref ref-type="bibr" rid="B66">2012</xref>; Antipova et al., <xref ref-type="bibr" rid="B4">2013</xref>; Hawlitschka et al., <xref ref-type="bibr" rid="B65">2013</xref>; Mehlan et al., <xref ref-type="bibr" rid="B94">2016</xref>) as a possible therapeutic option in experimental PD-model. In hemi-PD rats established by unilateral injection of 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB; Ungerstedt, <xref ref-type="bibr" rid="B146">1968</xref>; Ungerstedt and Arbuthnott, <xref ref-type="bibr" rid="B147">1970</xref>; Meredith et al., <xref ref-type="bibr" rid="B95">2008</xref>), intraperitoneally applied atropine antagonized profound PD-typical akinesia (Schallert et al., <xref ref-type="bibr" rid="B126">1978</xref>) and in combination with L-DOPA suppressed pathological circling of hemi-PD rats (Schallert et al., <xref ref-type="bibr" rid="B124">1979</xref>). In our previous studies (Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>) application of BoNT-A into the CPu ipsilateral to the dopaminergic depletion caused a long-term abolition of the pathological apomorphine-induced rotations. We hypothesized that due to the BoNT-A-application into the hypo-dopaminergic and hyper-cholinergic striatum of hemi-PD rats the cholinergic transmission is blocked thus leading to reduced pathological compensatory effects in this model.</p>
<p>In order to test our hypothesis that intrastriatal BoNT-A-application interferes with the 6-OHDA-induced hypercholinism (DeBoer et al., <xref ref-type="bibr" rid="B38">1993</xref>) and/or the D<sub>2</sub>-receptor upregulation (Creese et al., <xref ref-type="bibr" rid="B32">1977</xref>) in the CPu, we injected in the present study the &#x0201C;effective&#x0201D; dose of BoNT-A (Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>) either into the CPu ipsilateral or contralateral to the dopaminergic deprivation. Here we show that at least some of the behavioral effects seen after ipsilateral BoNT-A-applications in hemi-PD rats should be reversed or even changed to the opposite by contralateral BoNT-A-injection in hemi-PD rats.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals</title>
<p>Adult male Wistar rats, purchased at Charles River WIGA (Sulzfeld, Germany) and weighing 290&#x02013;310 g at the time of first surgery were used. Rats were housed in standard cages at 22 &#x000B1; 2&#x000B0;C under 12 h light/12 h dark cycle with free access of standard food and water. At the end of the experiments mean body weights were as follows: ipsilateral BoNT-A group 559.4 g &#x000B1; 20.0; ipsilateral sham group 558.4 g &#x000B1; 23.71; contralateral BoNT-A group 558.5 g &#x000B1; 16.16; contralateral sham group 555.3 g &#x000B1; 17.52.</p>
</sec>
<sec id="s2-2">
<title>Stereotactic Intervention of Animal Groups</title>
<p>All animals got a 6-OHDA-injection into the MFB of the right hemisphere (hemi-PD), and the successfully lesioned rats were divided into two groups: (1) 6-OHDA-lesioned animals receiving BoNT-A into the CPu of the right hemisphere (ipsilateral BoNT-A group); and (2) 6-OHDA-lesioned animals receiving BoNT-A into the CPu of the left hemisphere (contralateral BoNT-A group), each group added with respectively sham-injected animals. All groups were created by the outcome of the apomorphine-induced rotational behavior after 6-OHDA in that the means of the BoNT-A-injected and the vehicle-injected rats inside (1) and (2) did not differ significantly. All experiments were approved by the State Animal Research Committee of Mecklenburg-Western Pomerania (LALLF M-V/TSD/7221.3-1.1-003/13).</p>
<p>Surgery was conducted under aseptic conditions under ketamine (50 mg/kg body weight)/xylazine (4 mg/kg body weight) anesthesia using a stereotactic frame (David Kopf Instruments). For nearly complete lesion of the right side substantia nigra compact part 4 &#x003BC;l 6-OHDA solution (24 &#x003BC;g, Sigma-Aldrich, St. Louis, MO, USA) dissolved in 0.1 M citrate buffer was injected over 4 min via a 26 gauge 5 &#x003BC;l Hamilton syringe into the MFB. The injection coordinates with reference to bregma were: anterior-posterior = &#x02212;2.3 mm, lateral = 1.5 mm and ventral = &#x02212;9.0 mm, respectively (Paxinos and Watson, <xref ref-type="bibr" rid="B200">2007</xref>; Figures <xref ref-type="fig" rid="F1">1A,B</xref>). The success of the lesion was evaluated with apomorphine-induced rotations 1 month after surgery. All animals displayed more than four contralateral rotations/min, indicating a unilateral death of about 97% of the nigrostriatal DAergic neurons (Ungerstedt and Arbuthnott, <xref ref-type="bibr" rid="B147">1970</xref>) and, therefore, were tested further. As reported previously (Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>; Hawlitschka et al., <xref ref-type="bibr" rid="B65">2013</xref>), 6 weeks after 6-OHDA-lesioning animals received injections of 2 &#x000D7; 1 &#x003BC;l BoNT-A solution (lot No. 13028A1A; List, Campbell, CA; purchased via Quadratech, Surrey, UK) containing a total of 1 ng BoNT-A dissolved in phosphate-buffered saline with 0.1% bovine serum albumin (PSA-BSA 0.1%) added into the right (ipsilateral) or left (contralateral) CPu. The coordinates with reference to bregma for the ipsilateral BoNT-A-application were: anterior = +1.3/&#x02212;0.4 mm, lateral 2.6/3.6 mm to the right, and ventral &#x02212;5.5 mm, respectively, those for the contralateral BoNT-A-application were: anterior = +1.3/&#x02212;0.4 mm, lateral 2.6/3.6 mm to the left, and ventral &#x02212;5.5 mm (Figures <xref ref-type="fig" rid="F1">1A,B</xref>). Coronal sections stained for cell bodies (Merker, <xref ref-type="bibr" rid="B96">1983</xref>) and myelin (Gallyas, <xref ref-type="bibr" rid="B57">1971</xref>, <xref ref-type="bibr" rid="B58">1979</xref>) depict injection site at &#x02212;0.4 mm, 3.6 mm and &#x02212;5.5 mm (Figures <xref ref-type="fig" rid="F1">1C,D</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Dorsal view of reconstructed rat brains. The location of the right side 6-hydroxydopamine (6-OHDA)-injection site in the medial forebrain bundle (MFB; white oval) anterior to the substantia nigra pars compacta (SNC) and the two injection sites of botulinum neurotoxin A (BoNT-A) or vehicle (yellow spots) in the caudate putamen (CPu) ipsilateral <bold>(A)</bold> and contralateral <bold>(B)</bold> to 6-OHDA are indicated. Adjacent 20 &#x003BC;m coronal sections of a rat brain stained for cell bodies <bold>(C)</bold> according to Merker or for myelin <bold>(D)</bold> according to Gallyas depict the needle tract (arrow) and the needle tip (asterisk) of a BoNT-A-injection ipsilateral to the 6-OHDA-application (9 months survival). Scale bar applies to <bold>(C,D)</bold>: 2 mm.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0001.tif"/>
</fig>
</sec>
<sec id="s2-3">
<title>Behavioral Testing</title>
<sec id="s2-3-1">
<title>Drug-Induced Rotation Tests (Apomorphine, Amphetamine)</title>
<p>Rotations were assessed using an automated, self-constructed rotometer system based on the design of Ungerstedt and Arbuthnott (<xref ref-type="bibr" rid="B147">1970</xref>) and defined as complete 360&#x000B0; turns and registered as net differences between the two directions per minute. Rotational behavior was induced by amphetamine and apomorphine in hemi-PD rats injected with BoNT-A. Tests were performed prior to (i.e., 4 weeks after 6-OHDA-lesion) and at five time points (2 weeks and 1, 3, 6 and 9 months) after intrastriatal application of BoNT-A (Figure <xref ref-type="fig" rid="F2">2</xref>). Animals were injected with d-amphetamine sulfate (2.5 mg/kg, s.c., Sigma Aldrich) and monitored for 60 min and in each case 3 days later with apomorphine (0.25 mg/kg, i.p.; Teclapharm, Germany), followed by registration of rotation for 40 min. In the hemi-PD rats, apomorphine-induced anti-clockwise rotations were expressed by positive values (Figure <xref ref-type="fig" rid="F3">3</xref>), whereas amphetamine-induced rotations in clockwise direction were expressed by negative values (Figure <xref ref-type="fig" rid="F4">4</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Time points of lesions and behavioral tests in rats BoNT-A or sham-injected <bold>(A)</bold> ipsilateral or <bold>(B)</bold> contralateral to 6-OHDA. Light gray rectangles symbolize batteries of spontaneous behavior tests performed subsequently: open field (OF) test, corridor task, stepping and cylinder tests. Dark gray rectangles symbolize amphetamine-induced rotation test followed by an apomorphine-induced rotation test 3 days later. <bold>(C)</bold> The battery of spontaneous behavior tests were performed as follows: each behavior test series lasted 10 days. At the first day rats were tested for 10 min in the OF arena. Thereafter, rats were food restricted and adapted 2 days rats to the corridor task apparatus for 10 min each. One day later the final corridor test was carried out for 5 min. At the following 3 days rats were handled by the experimentator for 5 min each day. On the following 3 days rats underwent the stepping test twice a day. On the 10th day the forepaw usage was evaluated by the cylinder test. <bold>(D)</bold> Finally, drug-induced rotation tests were performed. First amphetamine rotation test was done for 60 min. Three days later rats were tested for apomorphine-induced rotations for 40 min.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0002.tif"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Apomorphine-induced rotations in hemi-Parkinson&#x02019;s disease (PD) rats treated with intrastriatal BoNT-A- or vehicle-applied <bold>(A)</bold> ipsilaterally or <bold>(B)</bold> contralaterally. Ipsilateral BoNT-A-injections significantly decreased anti-clockwise rotations 4 weeks and 3 months compared to sham injection. Contralateral BoNT-A-injection caused a significant increase of the turning rate only 2 weeks after surgery. Asterisks indicate significant differences compared to the sham group (*<italic>P</italic> &#x0003C; 0.05). Hashtags indicate significant differences compared to values before BoNT-A-injection (<sup>&#x00023;&#x00023;</sup><italic>P</italic> &#x0003C; 0.01). Paragraphs indicate significant differences compared to the previous value after BoNT-A-injection (<sup>&#x000A7;&#x000A7;&#x000A7;</sup><italic>P</italic> &#x0003C; 0.001). Data are represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0003.tif"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Amphetamine-induced rotations in hemi-PD rats treated with intrastriatal BoNT-A-or vehicle-applied <bold>(A)</bold> ipsilaterally or <bold>(B)</bold> contralaterally. Ipsilateral BoNT-A-injection caused significantly increased rotations 4 weeks to 6 months after BoNT-A, while sham-injected rats did not change rotational behavior. Contralateral BoNT-A-injection in hemi-PD rats caused no significant change of rotational behavior compared to the sham group. Asterisks indicate significant differences compared to the sham group (*<italic>P</italic> &#x0003C; 0.05). Hashtags indicate significant differences compared to values before BoNT-A-injection (<sup>&#x00023;&#x00023;</sup><italic>P</italic> &#x0003C; 0.01, <sup>&#x00023;&#x00023;&#x00023;</sup><italic>P</italic> &#x0003C; 0.001). Data are represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0004.tif"/>
</fig>
</sec>
<sec id="s2-3-2">
<title>Spontaneous Motor Tests</title>
<p>Corridor task, stepping and open field (OF) tests were realized before 6-OHDA-lesion and 4 weeks thereafter, and 4 weeks, 3 and 6 months after ipsilateral intrastriatal injection of BoNT-A or vehicle, or 2 and 4 weeks, 3, 6 and 9 months after contralateral intrastriatal injection of BoNT-A or vehicle (Figure <xref ref-type="fig" rid="F2">2</xref>). Cylinder test was performed after 6-OHDA-lesion and 4 weeks, 3, 6, 9 and 12 months after ipsilateral intrastriatal injection of BoNT-A or vehicle, or before 6-OHDA-lesion and 4 weeks thereafter, and 2 and 4 weeks, 3, 6 and 9 months after contralateral intrastriatal injection of BoNT-A or vehicle (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
</sec>
<sec id="s2-3-3">
<title>Stepping Test</title>
<p>Forelimb akinesia was assessed using a modified version of a stepping test (Olsson et al., <xref ref-type="bibr" rid="B103">1995</xref>) primary described as bracing test by Schallert et al. (<xref ref-type="bibr" rid="B124">1979</xref>) and has been established as a sensitive measure of bradykinesia in unilateral 6-OHDA-lesioned rats (Schallert et al., <xref ref-type="bibr" rid="B125">1992</xref>; Lindner et al., <xref ref-type="bibr" rid="B86">1997</xref>). We evaluated the adjusting steps. Rats were handled by the experimenter during 3 days to become familiar with the test procedure. Thereafter, tests were performed twice per day on three consecutive days. Briefly, the rat was held by the investigator with one hand softly blocking both its hind limbs and the not monitored forelimb, the unrestrained forepaw touching the table. In doing so the rat was moved slowly sideways across the table (0.9 m in 5 s) and the number of adjusting steps of the respective unrestrained left or right forepaw was counted while moving in the forehand and backhand directions. Finally, the means of forehand and backhand steps of left and right paws were calculated.</p>
</sec>
<sec id="s2-3-4">
<title>Cylinder Test</title>
<p>Forelimb preference was evaluated with the cylinder test in both groups. The use of the left and right forepaws during vertical exploration in a glass cylinder with a diameter of 20 cm was documented and analyzed with a video camera system (Sony) according to Schallert and Tillerson (<xref ref-type="bibr" rid="B122">2000</xref>) and Kirik et al. (<xref ref-type="bibr" rid="B77">2001</xref>). Thirty consecutive forepaw contacts with the glass cylinder were evaluated per animal by counting the initial contacts of the right or left paw and calculating the ratio of left and right forepaw use. To prevent subjective bias, contacts made by each forepaw with the cylinder wall were scored from videotapes by an observer blinded to the animals&#x02019; identities.</p>
</sec>
<sec id="s2-3-5">
<title>Open Field Test</title>
<p>Spontaneous horizontal locomotor activity and anxiety were estimated via the OF test (Hall and Ballachey, <xref ref-type="bibr" rid="B63">1932</xref>; Hall, <xref ref-type="bibr" rid="B62">1934</xref>). Rats were placed in a square OF arena of 50 &#x000D7; 50 cm, which was positioned inside an isolation box (TSE-Systems, Bad Homburg, Germany). Rats were adapted for 1 h before the test at dark-phase in the examination room. Illumination of the OF test was provided by a white photo bulb at 450 lx and animals were monitored online by a video camera placed inside the isolation box and tracked using the VideoMot2 Software (TSE Systems). The OF was divided into 16 quadratic subfields in 12 peripheral and four central area by a grid in the tracking software. This paradigm mimicked the natural conflict in rats between the tendency to explore a novel environment and the tendency to avoid a brightly lit open arena (DeFries et al., <xref ref-type="bibr" rid="B39">1966</xref>; Eikelis and Van Den Buuse, <xref ref-type="bibr" rid="B48">2000</xref>). The rats were tested once in the arena for 10 min. Environmental odors were removed by cleaning the OF after each session to avoid influences of the behavior by odor trials. The total running distance of the animals, time spend in the center and in the edges of OF arena (Andringa et al., <xref ref-type="bibr" rid="B3">2000</xref>), also the ration of center distance to total distance (Denenberg, <xref ref-type="bibr" rid="B41">1969</xref>) were evaluated.</p>
</sec>
<sec id="s2-3-6">
<title>Corridor Task</title>
<p>Lateralized sensorimotor integration and neglect for the side contralateral to the 6-OHDA-lesion were examined using the adjacent version of corridor task according to Grealish et al. (<xref ref-type="bibr" rid="B61">2010</xref>). Before testing rats went onto a food restriction diet for 3 days and maintained at 90% of free-feeding bodyweight during habituation and testing (Schackel et al., <xref ref-type="bibr" rid="B121">2013</xref>). Animals were adapted into the apparatus, a long, narrow self-constructed alleyway (240 cm long &#x000D7; 7 cm wide &#x000D7; 23 cm deep) for 10 min each on two consecutive days with some scattered sugar pellets (Ain-76A Rodent Tablet 20 mg TestDiet, Richmond, IN, USA) along the floor of the corridor and started from different ends of the corridor each day. On the test day, rats were first positioned individually in an identical, but empty corridor for 5 min for adaptation and then placed to the end of the testing corridor in which bowls (2 cm in diameter, distance between the bowls 15 cm) containing 5 pellets placed on the left and right sides. Rats were free to retrieve pellets from either side of their body for 5 min (Fitzsimmons et al., <xref ref-type="bibr" rid="B54">2006</xref>). The number of ipsilateral (right side) and contralateral (left side) retrievals was counted and the data were expressed as the percentage of left or right side retrievals on the total number of retrievals. A &#x0201C;retrieval&#x0201D; involved a nose poke into a bowl, whether or not any pellets were taken from it, defining the side according to the rat&#x02019;s body axis (Dowd et al., <xref ref-type="bibr" rid="B45">2005</xref>; D&#x000F6;br&#x000F6;ssy and Dunnett, <xref ref-type="bibr" rid="B44">2007</xref>; Grealish et al., <xref ref-type="bibr" rid="B61">2010</xref>).</p>
</sec>
<sec id="s2-3-7">
<title>Statistics</title>
<p>Data of behavioral tests was subjected to two-way ANOVA with repeated measurements. A one-way repeated measures ANOVA is used for comparison of different time points in separate treatment groups which is essentially the same design as a paired <italic>t</italic>-test. The Holm-Sidak approach was used for adjustment for multiple testing for <italic>post hoc</italic> comparisons. A critical value for significance of <italic>P</italic> &#x02264; 0.05 was used throughout the study. In case of non-normally distributed data, data were subjected to Kruskal-Wallis one- or two-way ANOVA on ranks. Dunn&#x02019;s test was used for <italic>post hoc</italic> comparisons after ANOVA on ranks to adjust for multiple testing. All statistical tests were done using SigmaPlot 11 Software (Supplementary Table S1).</p>
</sec>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Apomorphine-Induced Rotations</title>
<p>The right side hemi-PD rats showed apomorphine-induced anti-clockwise rotations of about 6&#x02013;10 rotations per minute (Figures <xref ref-type="fig" rid="F3">3A,B</xref>).</p>
<sec id="s3-1-1">
<title>Ipsilateral BoNT-A-Injection</title>
<p>Ipsilateral BoNT-A-injection caused a significant decrease in rotational behavior 4 weeks and 3 months after BoNT-A, thereafter rotations of BoNT-A-injected rats equaled those after sham-injection (Figure <xref ref-type="fig" rid="F3">3A</xref>).</p>
</sec>
<sec id="s3-1-2">
<title>Contralateral BoNT-A-Injection</title>
<p>The injection of 1 ng BoNT-A into the left striatum of right sided 6-OHDA-lesioned rats caused a significant increase of the turning rate 2 weeks after surgery. Remarkably, already 2 weeks later, i.e., 1 month after BoNT-A-administration, the turning rate decreased to a level, which was not significantly different from the turning rate prior to BoNT-A treatment (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p>
</sec>
</sec>
<sec id="s3-2">
<title>Amphetamine-Induced Rotations</title>
<p>The hemi-PD rats showed amphetamine-induced clockwise rotations of about seven turns per minute (Figures <xref ref-type="fig" rid="F4">4A,B</xref>).</p>
<sec id="s3-2-1">
<title>Ipsilateral BoNT-A-Injection</title>
<p>Ipsilateral intrastriatal BoNT-A-injection caused a significantly increase of the turning rate 4 weeks to 6 months after BoNT-A (Figure <xref ref-type="fig" rid="F4">4A</xref>). Sham-injected rats did not change rotational behavior in hemi-PD rats (Figure <xref ref-type="fig" rid="F4">4A</xref>).</p>
</sec>
<sec id="s3-2-2">
<title>Contralateral BoNT-A-Injection</title>
<p>Contralateral intrastriatal BoNT-A-injection in hemi-PD rats caused a tentative decrease of rotational behavior only at 2 weeks after BoNT-A (Figure <xref ref-type="fig" rid="F4">4B</xref>). At all other post-BoNT-A-injection time-points BoNT-A- and sham-injected rats did not differ in rotational behavior in hemi-PD rats (Figure <xref ref-type="fig" rid="F4">4B</xref>).</p>
</sec>
</sec>
<sec id="s3-3">
<title>Stepping Test</title>
<p>Adjusting steps were measured on the unlesioned and lesioned sides for each group in the forward and backward directions. Before 6-OHDA-lesion no difference in the number of adjusting steps for the left and right forepaws in forehand and backhand directions for both experimental groups were observed (Figures <xref ref-type="fig" rid="F5">5A&#x02013;H</xref>). Rats of both groups with their left and right forepaws made about 9&#x02013;12 steps both in forward and backward directions. After 6-OHDA-lesion only the performance of the left forepaw (contralateral to 6-OHDA) was impaired in both the forehand (Figures <xref ref-type="fig" rid="F5">5A,B</xref>) and backhand (Figures <xref ref-type="fig" rid="F5">5C,D</xref>) directions.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>Stepping test in right side hemi-PD rats treated with intrastriatal BoNT-A- or vehicle-applied <bold>(A,C,E,G)</bold> ipsilaterally or <bold>(B,D,F,H)</bold> contralaterally. In unlesioned rats 9&#x02013;12 adjusting steps for the left <bold>(A&#x02013;D)</bold> and right <bold>(E&#x02013;H)</bold> forelimbs in forehand and backhand directions were seen. In hemi-PD rats the use of the left forepaw was impaired in both the forehand <bold>(A,B)</bold> and backhand <bold>(C,D)</bold> directions. Neither ipsilateral BoNT-A nor sham injection changed the impairments of left paw steps in hemi-PD rats <bold>(A,C)</bold>. The stepping of the right forelimb in hemi-PD rats in both the forehand <bold>(E)</bold> and backhand <bold>(G)</bold> directions were generally not affected by ipsilateral BoNT-A or sham injection. Contralateral BoNT-A-injected hemi-PD rats significantly improved left paw forehand steps from 2 weeks to 3 months after BoNT-A <bold>(B)</bold>, and backhand steps from 2 weeks until 9 months after BoNT-A <bold>(D)</bold>. Right forepaw adjusting steps significantly increased from 2 weeks up to 9 months after BoNT-A-application as well in forehand <bold>(F)</bold> as in backhand <bold>(H)</bold> directions compared to sham-injected rats. Asterisks indicate significant differences compared to the sham group (*<italic>P</italic> &#x0003C; 0.05, **<italic>P</italic> &#x0003C; 0.01, ***<italic>P</italic> &#x0003C; 0.001). Data are represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0005.tif"/>
</fig>
<sec id="s3-3-1">
<title>Ipsilateral BoNT-A-Injection</title>
<p>Neither ipsilateral BoNT-A nor sham injections changed the impairments of hemi-PD rats. At the same time, side stepping movements of the right forepaw in 6-OHDA-lesioned rats in both the forehand and backhand directions were generally neither affected by ipsilateral BoNT-A nor sham injection up to 6 months (Figures <xref ref-type="fig" rid="F5">5E,G</xref>), with exception of single time points.</p>
</sec>
<sec id="s3-3-2">
<title>Contralateral BoNT-A-Injection</title>
<p>As compared to sham-injected rats, the BoNT-A-injected animals significantly improved left paw forehand steps from 2 weeks to 3 months after BoNT-A (Figure <xref ref-type="fig" rid="F5">5B</xref>), and backhand steps from 2 weeks until 9 months after BoNT-A (Figure <xref ref-type="fig" rid="F5">5D</xref>). In addition, we found significantly more adjusting steps of the right forepaw from 2 weeks up to 9 months after BoNT-A-application as compared to sham-injected rats, as well in forehand (Figure <xref ref-type="fig" rid="F5">5F</xref>) as in backhand (Figure <xref ref-type="fig" rid="F5">5H</xref>) directions. Thus, contralateral BoNT-A-injection positively influences forelimb usage in hemi-PD rats. Moreover, there was an age-related decrease in right paw stepping (Figures <xref ref-type="fig" rid="F5">5F,H</xref>).</p>
</sec>
</sec>
<sec id="s3-4">
<title>Cylinder Test</title>
<p>Right side hemi-PD rats exhibited a significantly reduced use of the left forelimb, resulting in an about 50% decrease of the left/right ratio of forelimb usage (Figures <xref ref-type="fig" rid="F6">6A,B</xref>).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>Cylinder test in right side hemi-PD rats treated with intrastriatal BoNT-A- or vehicle-applied <bold>(A)</bold> ipsilaterally or <bold>(B)</bold> contralaterally. Hemi-PD rats exhibited a significantly reduced use of the left forelimb resulting in left/right ratio of about 0.5 <bold>(A,B)</bold>. Neither ipsilateral BoNT-A nor sham injection showed any significant improvement. Contralateral intrastriatal injection of BoNT-A only led at 2 weeks after BoNT-A to a significant readjustment of the right and left forepaw usage. Hashtags indicate significant differences compared to values before BoNT-A-injection (<sup>&#x00023;&#x00023;&#x00023;</sup><italic>P</italic> &#x0003C; 0.001). Asterisks indicate significant differences compared to the sham group (***<italic>P</italic> &#x0003C; 0.001). Data are represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0006.tif"/>
</fig>
<sec id="s3-4-1">
<title>Ipsilateral BoNT-A-Injection</title>
<p>Intrastriatal ipsilateral treatment of hemi-PD rats with 1 ng of BoNT-A did not show any significant improvement of the left forelimb usage as assessed by the cylinder test. Also sham-treated rats showed no significant effect in forelimb usage of hemi-PD rats (Figure <xref ref-type="fig" rid="F6">6A</xref>).</p>
</sec>
<sec id="s3-4-2">
<title>Contralateral Injection</title>
<p>Interestingly, intrastriatal injection of BoNT-A contralateral to the lesioned side led 2 weeks after BoNT-A-application to a significant readjustment of the left and right forepaw usage. In the course of the following months this effect decreased (Figure <xref ref-type="fig" rid="F6">6B</xref>).</p>
</sec>
</sec>
<sec id="s3-5">
<title>Open Field</title>
<p>Hemi-PD rats of both BoNT-A- and sham-injected groups showed decreased locomotor activity compared to prelesion results (Figure <xref ref-type="fig" rid="F7">7B</xref>).</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption><p>OF test in right side hemi-PD rats treated with intrastriatal BoNT-A- or vehicle-applied <bold>(A,C)</bold> ipsilaterally or <bold>(B,D)</bold> contralaterally. Rats of both BoNT-A- and sham-injected groups showed decreased locomotor activity compared to prelesion results <bold>(B)</bold>. Neither ipsilateral BoNT-A nor sham injection showed any significant changes in total running distance <bold>(A)</bold> or the ratio of center distance to total distance <bold>(C)</bold>. The same is true for both contralaterally injected groups <bold>(B,D)</bold>. Data are represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0007.tif"/>
</fig>
<sec id="s3-5-1">
<title>Ipsilateral BoNT-A-Injection</title>
<p>The total running distance (Figure <xref ref-type="fig" rid="F7">7A</xref>) and also the ratio of center distance to total distance (Figure <xref ref-type="fig" rid="F7">7C</xref>) were not significantly different between the BoNT-A and the sham group over time. Moreover, ipsilateral BoNT-A-injected rats and sham group spent the same time in the edges of the OF apparatus (data not shown).</p>
</sec>
<sec id="s3-5-2">
<title>Contralateral BoNT-A-Injection</title>
<p>The total running distance was similar in both experimental groups after contralateral application of BoNT-A or sham treatment up to 9 months (Figure <xref ref-type="fig" rid="F7">7B</xref>). Also, the relative center distance (Figure <xref ref-type="fig" rid="F7">7D</xref>) of the BoNT-A-injected animals did not differ significantly from the sham group over time as did the times spent in the edges of the OF (data not shown).</p>
</sec>
</sec>
<sec id="s3-6">
<title>Corridor Task</title>
<p>Two weeks before lesion surgery, rats were tested in the adjacent version of the corridor task. This preoperative screening showed that all animals equally retrieved pellets from either left or right sides (Figures <xref ref-type="fig" rid="F8">8A,B</xref>). The right side 6-OHDA-lesion caused a significant neglect of the left corridor side; only about 5% of left retrievals were measured (Figures <xref ref-type="fig" rid="F8">8A,B</xref>).</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption><p>Corridor task in hemi-PD rats treated with intrastriatal BoNT-A- or vehicle-applied <bold>(A)</bold> ipsilaterally or <bold>(B)</bold> contralaterally. Preoperative screening showed that all animals equally retrieved pellets from either left or right sides <bold>(A,B)</bold>. Right side hemi-PD rats significantly neglected of the left corridor side. Ipsilateral BoNT-A as well as sham injections did not improve contralateral sensorimotor integration in hemi-PD rats. Contralateral BoNT-A-injection reversed this bias in hemi-PD rats 2 weeks to 9 months. Significant contralateral retrievals of about 40% were seen. Left side sham-injected rats did not improve in this task over time. Asterisks indicate significant differences compared to the sham group (**<italic>P</italic> &#x0003C; 0.01). Hashtags indicate significant differences compared to values before BoNT-A-injection (<sup>&#x00023;&#x00023;&#x00023;</sup><italic>P</italic> &#x0003C; 0.001). Data are represented as mean &#x000B1; SEM.</p></caption>
<graphic xlink:href="fnbeh-11-00119-g0008.tif"/>
</fig>
<sec id="s3-6-1">
<title>Ipsilateral BoNT-A-Injection</title>
<p>Ipsilateral intrastriatal BoNT-A as well as sham injections in hemi-PD rats did not improve contralateral sensorimotor integration up to 6 months significantly (Figure <xref ref-type="fig" rid="F8">8A</xref>).</p>
</sec>
<sec id="s3-6-2">
<title>Contralateral BoNT-A-Injection</title>
<p>Left side sham-injected rats did not improve in this task over time. In contrast, contralateral intrastriatal BoNT-A-injection significantly reversed this bias 2 weeks to 9 months after treatment. Significant contralateral retrievals of about 40% were seen. However, 6 and 9 months after BoNT-A values declined again and equaled those of sham-injected rats (Figure <xref ref-type="fig" rid="F8">8B</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In our previous publications (Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>; Holzmann et al., <xref ref-type="bibr" rid="B66">2012</xref>; Antipova et al., <xref ref-type="bibr" rid="B4">2013</xref>; Hawlitschka et al., <xref ref-type="bibr" rid="B65">2013</xref>; Mehlan et al., <xref ref-type="bibr" rid="B94">2016</xref>), we described the effect of intrastriatal injection of BoNT-A in a rat model of hemi-PD. We used the 6-OHDA to induce hemi-PD, a widely utilized and highly reproducible toxin-based animal model of PD in rats (Ungerstedt et al., <xref ref-type="bibr" rid="B149">1974</xref>; Schwarting and Huston, <xref ref-type="bibr" rid="B131">1996</xref>; Deumens et al., <xref ref-type="bibr" rid="B42">2002</xref>; Blandini and Armentero, <xref ref-type="bibr" rid="B12">2012</xref>). Unilateral 6-OHDA-injection of the right MFB that conveys the efferent fibers from nigral cell bodies to the striatum, causes massive degeneration of the nigrostriatal pathway, highest level of nigral cell loss and striatal DA depletion (over 90%; Dauer and Przedborski, <xref ref-type="bibr" rid="B35">2003</xref>; Blandini and Armentero, <xref ref-type="bibr" rid="B12">2012</xref>). The resulting motor deficits at the side of the body contralateral to the lesion (Deumens et al., <xref ref-type="bibr" rid="B42">2002</xref>) can be evaluated by spontaneous and drug-induced behavioral phenotypes. As described originally by Ungerstedt and Arbuthnott (<xref ref-type="bibr" rid="B147">1970</xref>), a 6-OHDA-lesion of the right SNC causes anti-clockwise, i.e., contraversive apomorphine-induced rotations (Ungerstedt et al., <xref ref-type="bibr" rid="B148">1969</xref>). The most important finding in our prior studies with intrastriatally applied BoNT-A was the complete abolition of apomorphine-induced rotations up to 6 months, when the rats received 1 ng of BoNT-A into the right striatum 6 weeks after right side 6-OHDA-lesion (Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>; Antipova et al., <xref ref-type="bibr" rid="B4">2013</xref>).</p>
<p>In continuation of previous studies and to enhance our knowledge of the BoNT-A-injection model, we here examined the effects of BoNT-A-injection into the striatum as well ipsilateral as contralateral to the hemisphere that received 6-OHDA before. For that reason we used a broad spectrum of different behavior tests, including spontaneous test, i.e., corridor task, stepping, cylinder and OF test and drug-induced motor tests, i.e., apomorphine- and amphetamine-induced rotations, to characterize and compare the effects of ipsilateral and contralateral intrastriatal BoNT-A-injections on the motor deficits, lateralized neglect, bradykinesia, emotionality and anxiety in hemi-PD rats.</p>
<p>We found a differentiated behavioral profile after ipsilateral or contralateral BoNT-A-application in hemi-PD rats. The effects of ipsilaterally injected BoNT-A were in line with those published previously (Wree et al., <xref ref-type="bibr" rid="B158">2011</xref>; Holzmann et al., <xref ref-type="bibr" rid="B66">2012</xref>; Antipova et al., <xref ref-type="bibr" rid="B4">2013</xref>; Hawlitschka et al., <xref ref-type="bibr" rid="B65">2013</xref>; Mehlan et al., <xref ref-type="bibr" rid="B94">2016</xref>). Interestingly, the effects of contralaterally injected BoNT-A were either changed to the opposite compared to ipsilateral BoNT-A, or gave results not known yet. The disruption of presynaptic ACh as well as DA release by BoNT-A is transient and the synaptic signal transmission was shown by forming of new intact SNARE complexes within several months (Sweeney et al., <xref ref-type="bibr" rid="B138">1989</xref>; Shapovalova, <xref ref-type="bibr" rid="B134">1995</xref>; Washbourne et al., <xref ref-type="bibr" rid="B151">1998</xref>; Weinstock et al., <xref ref-type="bibr" rid="B152">2002</xref>). In the following paragraphs, the results seen in the various behavioral parameters are discussed with respect to assumed or hypothetical changes of transmitter and receptor concentrations in the CPu as a key structure of the basal ganglia loops induced by dopaminergic deprivation and BoNT-A-application.</p>
<sec id="s4-1">
<title>Basal Ganglia Circuitry in Hemi-PD Rats</title>
<p>Dopaminergic deprivation of the striatum is followed by reactive adaptations of transmitter receptors, mainly by an upregulation of D2 receptors in the range of about 20%&#x02013;30% (Reader and Dewar, <xref ref-type="bibr" rid="B114">1999</xref>; Choi et al., <xref ref-type="bibr" rid="B27">2012</xref>; Sun et al., <xref ref-type="bibr" rid="B137">2013</xref>; Konieczny et al., <xref ref-type="bibr" rid="B79">2017</xref>). The majority of inhibitory D2 receptors are located on cholinergic interneurons and medium spiny neurons (MSN) projecting to the external pallidum, i.e., being part of the indirect basal ganglia loop (Hurley and Jenner, <xref ref-type="bibr" rid="B69">2006</xref>; Perreault et al., <xref ref-type="bibr" rid="B105">2011</xref>; Bordia et al., <xref ref-type="bibr" rid="B15">2016</xref>; Mamaligas et al., <xref ref-type="bibr" rid="B91">2016</xref>; Rico et al., <xref ref-type="bibr" rid="B116">2017</xref>). As in hemi-PD the tonically active cholinergic interneurons become hyperactive due to loss of D2-mediated DA inhibition, they strongly activate MSN by ACh. Thus, complementary to the loss of inhibitory D2-mediated DA inhibition the MSN increase their firing intensity also by cholinergic hyperstimulation. The increased GABAergic MSN projection reaches the external globus pallidus (EGP). As the EGP is thus strongly inhibited, its GABAergic projection to the internal globus pallidus (IGP = entopeduncular nucleus) and mainly to the subthalamic nucleus (STh) is strongly reduced compared to normal. As a result, the spontaneously active STh is less inhibited and thus more intensely firing, further stimulated by normal cortical glutamatergic afferents. As a consequence, the STh using glutamate as transmitter can stimulate the IGP more intensely. The massively stimulated IGP projects using GABA as transmitter to the ventrolateral thalamic nucleus (VL) that reacts with an inhibition of its neurons. Finally, the inhibited VL neurons send less activating glutamatergic stimuli to the premotor cortex that in turn reacts with a reduced initiation of movements of the contralateral body via its crossed motor efferents (Obeso et al., <xref ref-type="bibr" rid="B100">2008a</xref>,<xref ref-type="bibr" rid="B101">b</xref>, <xref ref-type="bibr" rid="B102">2014</xref>). These changes in basal ganglia circuitry seem to underlie the movement initiation deficits, the akinesia and the reduced spontaneous use of the contralateral forelimb and changed walking pattern in hemi-PD rats (Blandini et al., <xref ref-type="bibr" rid="B13">2000</xref>; DeLong and Wichmann, <xref ref-type="bibr" rid="B40">2007</xref>; Braak and Del Tredici, <xref ref-type="bibr" rid="B16">2008</xref>; Quiroga-Varela et al., <xref ref-type="bibr" rid="B112">2013</xref>; Tremblay et al., <xref ref-type="bibr" rid="B142">2015</xref>).</p>
</sec>
<sec id="s4-2">
<title>Drug-Induced Behavior</title>
<sec id="s4-2-1">
<title>Apomorphine-Induced Rotations</title>
<p>Unilateral dopaminergic depletion led to apomorphine-induced contralateral rotations, ipsilateral intrastriatal BoNT-A reduced rotational behavior for at least 6 months, and contralateral intrastriatal BoNT-A increased rotational behavior only shortly at 2 weeks after BoNT-A in hemi-PD rats.</p>
<p>In hemi-PD rats apomorphine-induced rotations are due to binding of apomorphine to the upregulated D2 receptors in the dopaminergically deprived CPu neurons (Konieczny et al., <xref ref-type="bibr" rid="B79">2017</xref>). Inhibitory D2 receptors are mostly located on cholinergic interneurons and MSN projecting to the EGP, i.e., being part of the indirect basal ganglia loop (Pisani et al., <xref ref-type="bibr" rid="B109">2007</xref>; Tozzi et al., <xref ref-type="bibr" rid="B141">2011</xref>; Lim et al., <xref ref-type="bibr" rid="B85">2014</xref>; Bordia et al., <xref ref-type="bibr" rid="B15">2016</xref>; Mamaligas et al., <xref ref-type="bibr" rid="B91">2016</xref>). In hemi-PD rats apomorphine deactivates the hyperactive cholinergic interneurons via D2 receptors and also inhibits the D2-bearing MSN, forming the central parts of the indirect basal ganglia loop and projecting with reduced intensity to the EGP. As the EGP is disinhibited, its GABAergic projection to the STh is increased compared to normal and thus the more inhibited STh can stimulate the IGP less intensively. The less active IGP projects less intensively to the VL, and consequently, the disinhibited VL sends much more activating stimuli to the premotor cortex, which in turn reacts with an increased initiation of movements and muscle innervation of the contralateral body side. Thus, apomorphine induces contralateral rotations in hemi-PD rats.</p>
<p>Ipsilateral intrastriatal application of 1 ng BoNT-A in hemi-PD rats completely abolished apomorphine-induced contralateral rotation behavior for at least 6 months. BoNT-A is thought to block the ACh release of cholinergic interneurons, which are hyperactive in PD (Day et al., <xref ref-type="bibr" rid="B36">2006</xref>; Obeso et al., <xref ref-type="bibr" rid="B100">2008a</xref>,<xref ref-type="bibr" rid="B101">b</xref>). Seemingly, ipsilateral BoNT-A normalized ACh concentration in the injected CPu for a limited time, i.e., up to 6 months until BoNT-A is metabolized. Moreover, jet unpublished own results of BoNT-A-induced receptor concentration measurements speak in favor of a BoNT-A-induced reduction of D2 receptors in the respective striatum. Following the indirect basal ganglia loop the reduced activity of the D2 receptor bearing MSN result in a downregulation, i.e., normalization of the VL activity and the abolition of apomorphine-induced contralateral rotation behavior. These effects seemed to exist for at least 3 months, thereafter BoNT should be metabolized.</p>
<p>Contralateral intrastriatal application of BoNT-A shortly increased apomorphine-induced contralateral rotation behavior only at 2 weeks. It can be hypothesized that BoNT-A shortly reduced the D2 receptors in the contralateral striatum thus increasing the difference in the D2 receptor concentrations between both hemispheres and by this leads to an increase of the number of rotations.</p>
</sec>
<sec id="s4-2-2">
<title>Amphetamine-Induced Rotations</title>
<p>Unilateral dopaminergic depletion led to amphetamine-induced ipsilateral rotations, ipsilateral intrastriatal BoNT-A increased rotational behavior for at least 6 months, and contralateral intrastriatal BoNT-A tentatively decreased rotational behavior shortly at 2 weeks after BoNT-A in hemi-PD rats.</p>
<p>Amphetamine as a DA releaser causes strong DA delivery in the CPu contralateral to the 6-OHDA-lesion and a low one in the ipsilateral striatum because of the loss of DA afferents. Consequently, the strong DA imbalance activates the contralateral inhibitory dopaminergic system, influencing the respective MSN via ACh, and by this causes ipsilateral rotations (about 7 per min). Moreover, the massive innervation of the D1 receptor bearing MSN in the CPu contralateral to the DA depletion also results in a stimulation of that hemisphere resulting in clockwise rotations of right side hemi-PD rats.</p>
<p>Ipsilateral intrastriatal application of 1 ng BoNT-A in hemi-PD rats increased amphetamine-induced ipsilateral rotation behavior for at least 6 months. Apparently, BoNT-A blocked the ACh release of cholinergic interneurons and reduced D2 receptor concentration in the respective striatum. Moreover, intrastriatal application of BoNT-A could have altered the concentration of other transmitters and their receptors, too (Bigalke et al., <xref ref-type="bibr" rid="B11">1985</xref>; Ashton and Dolly, <xref ref-type="bibr" rid="B6">1988</xref>; Poulain et al., <xref ref-type="bibr" rid="B111">1990</xref>). As it is described that amphetamine and its derivates are able to bind directly to &#x003B1;-2 adrenergic receptors (Ritz and Kuhar, <xref ref-type="bibr" rid="B117">1989</xref>) and activate serotonin receptors (Nichols et al., <xref ref-type="bibr" rid="B99">1994</xref>; Schmidt et al., <xref ref-type="bibr" rid="B127">1994</xref>), these receptors could also play a role in the BoNT-A-induced changes in amphetamine-induced rotation behavior.</p>
<p>Amphetamine-induced ipsilateral rotations were tentatively and shortly decreased at 2 weeks after contralateral intrastriatal BoNT-A-application. Possibly, BoNT-A temporally reduced DA release in the injected contralateral striatum thus decreasing the difference in the DA concentrations between both hemispheres and by this leading to a decrease of the number of rotations.</p>
</sec>
</sec>
<sec id="s4-3">
<title>Spontaneous Motor Tests</title>
<sec id="s4-3-1">
<title>Stepping Test</title>
<p>Unilateral right side dopaminergic depletion profoundly impaired stepping performance of the left paw (contralateral to 6-OHDA-lesion) in both forehand and backhand directions. Ipsilateral intrastriatal BoNT-A did not change the impairments seen in hemi-PD rats, while contralateral intrastriatal BoNT-A improved left paw forehand and backhand steps and positively influenced right forelimb usage.</p>
<p>In hemi-PD rats our results confirmed those of many others (Schallert et al., <xref ref-type="bibr" rid="B125">1992</xref>; Mukhida et al., <xref ref-type="bibr" rid="B97">2001</xref>; Kelsey et al., <xref ref-type="bibr" rid="B74">2004</xref>; Tseng et al., <xref ref-type="bibr" rid="B144">2005</xref>; Manfredsson et al., <xref ref-type="bibr" rid="B92">2007</xref>; Pioli et al., <xref ref-type="bibr" rid="B107">2008</xref>; Fang et al., <xref ref-type="bibr" rid="B50">2010</xref>; Seeger-Armbruster and von Ameln-Mayerhofer, <xref ref-type="bibr" rid="B132">2013</xref>; Shin et al., <xref ref-type="bibr" rid="B136">2014</xref>; Tronci et al., <xref ref-type="bibr" rid="B143">2015</xref>) showing the severe impairment of the contralateral paw in combination with unaltered stepping performance of the ipsilateral paw (Winkler et al., <xref ref-type="bibr" rid="B155">1996</xref>; Kelsey et al., <xref ref-type="bibr" rid="B74">2004</xref>; Pinna et al., <xref ref-type="bibr" rid="B106">2010</xref>). The motor initiation deficits in the forelimbs, analogous to limb akinesia and gait problems in PD patients, were produced by DA depletion (Sabol et al., <xref ref-type="bibr" rid="B118">1985</xref>; Fairley and Marshall, <xref ref-type="bibr" rid="B49">1986</xref>; Salamone et al., <xref ref-type="bibr" rid="B119">1993</xref>). As dopaminergic deprivation of the striatum is followed by increased GABAergic MSN projection to the EGP, resulting in a disinhibition of the spontaneously active STh and, as a result a more actively firing IGP, which inhibits VL. Finally, the inhibited VL neurons do not sufficiently activate the premotor cortex that in turn reduces initiation of movements of the contralateral body via its crossed motor efferents (Obeso et al., <xref ref-type="bibr" rid="B100">2008a</xref>,<xref ref-type="bibr" rid="B101">b</xref>, <xref ref-type="bibr" rid="B102">2014</xref>; Wree and Schmitt, <xref ref-type="bibr" rid="B157">2015</xref>).</p>
<p>Ipsilateral intrastriatal application of 1 ng BoNT-A in hemi-PD rats did not change the impairments seen in hemi-PD rats. Obviously, the BoNT-A-induced changes in the DA-deprived CPu concerning extracellular ACh content, and DA and other transmitter receptors are not sufficient to improve spontaneous motor tasks. Importantly, several reports emphasized that it is the striatal DA depletion of over 80% that is responsible for decreased movement initiation (Sabol et al., <xref ref-type="bibr" rid="B118">1985</xref>; Fairley and Marshall, <xref ref-type="bibr" rid="B49">1986</xref>; Salamone et al., <xref ref-type="bibr" rid="B119">1993</xref>; Chang et al., <xref ref-type="bibr" rid="B25">1999</xref>; Seeger-Armbruster and von Ameln-Mayerhofer, <xref ref-type="bibr" rid="B132">2013</xref>; Sun et al., <xref ref-type="bibr" rid="B137">2013</xref>). As in our hemi-PD rats the DA depletion was nearly complete (Barn&#x000E9;oud et al., <xref ref-type="bibr" rid="B8">2000</xref>; Kelsey et al., <xref ref-type="bibr" rid="B74">2004</xref>), the ipsilateral intrastriatal BoNT-A-application is without effect on stepping tasks.</p>
<p>Contralateral intrastriatal application of 1 ng BoNT-A in hemi-PD rats improved the impairments of the left paw seen in hemi-PD rats for 3 (forehand steps) or 9 (backhand steps) months. This phenomenon is not fully understood. D1 and D2 receptor binding contralateral to unilateral 6-OHDA-lesion is reported unchanged to normal rats (Lawler et al., <xref ref-type="bibr" rid="B83">1995</xref>; Pelled et al., <xref ref-type="bibr" rid="B104">2002</xref>), whereas D2 receptor concentration is generally increased ipsilaterally (Araki et al., <xref ref-type="bibr" rid="B5">1998</xref>; Reader and Dewar, <xref ref-type="bibr" rid="B114">1999</xref>; Choi et al., <xref ref-type="bibr" rid="B27">2012</xref>; Sun et al., <xref ref-type="bibr" rid="B137">2013</xref>; Konieczny et al., <xref ref-type="bibr" rid="B79">2017</xref>). This is corroborated by Capper-Loup et al. (<xref ref-type="bibr" rid="B21">2013</xref>) stating that contralateral to the 6-OHDA-lesion striatal D1R mRNA and D2R mRNA resemble those of naive rats, whereas ipsilaterally D1R mRNA is reduced and D2R mRNA is increased (Capper-Loup et al., <xref ref-type="bibr" rid="B21">2013</xref>). With respect to DA concentration in the contralateral hemisphere contradicting measures were reported. Fox et al. (<xref ref-type="bibr" rid="B56">2016</xref>) found striatal DA release from the contralateral unlesioned substantia nigra equivalent in lesioned and control rats, whereas Zetterstr&#x000F6;m et al. (<xref ref-type="bibr" rid="B160">1986</xref>) dialyzed more DA contralaterally to 6-OHDA than in unleased controls (Zetterstr&#x000F6;m et al., <xref ref-type="bibr" rid="B160">1986</xref>; Fox et al., <xref ref-type="bibr" rid="B56">2016</xref>). Several groups hypothesized that if it is likely that the unilateral lesion of the nigrostriatal pathways affects both sides of the brain (Lawler et al., <xref ref-type="bibr" rid="B83">1995</xref>; Fox et al., <xref ref-type="bibr" rid="B56">2016</xref>), then it is not yet clear how the unlesioned side is influenced. It is discussed that Interhemispheric projections have functional significance (Fox et al., <xref ref-type="bibr" rid="B56">2016</xref>; Schmitt et al., <xref ref-type="bibr" rid="B128">2016</xref>). Lawler et al. (<xref ref-type="bibr" rid="B83">1995</xref>) combined a 6-OHDA with a corpus callosum transection in order to minimize interhemispheric projections on possible changes in the D1 and D2 receptors, DA and its metabolites in the non-lesioned striatum (Lawler et al., <xref ref-type="bibr" rid="B83">1995</xref>). Bilateral cortico-striatal projections were traced in rats (Hassler et al., <xref ref-type="bibr" rid="B64">1982</xref>; Berendse et al., <xref ref-type="bibr" rid="B10">1992</xref>), however with ipsilateral predominance: both cortices project to both striata (Hassler et al., <xref ref-type="bibr" rid="B64">1982</xref>; Berendse et al., <xref ref-type="bibr" rid="B10">1992</xref>; Lieu and Subramanian, <xref ref-type="bibr" rid="B84">2012</xref>; Schmitt et al., <xref ref-type="bibr" rid="B128">2016</xref>), i.e., intact cortex to the lesioned striatum and cortex of the lesioned hemisphere to the intact striatum (Lieu and Subramanian, <xref ref-type="bibr" rid="B84">2012</xref>) arguing that interhemispheric connections can influence behavioral responses to nigrostriatal lesioning. Unfortunately, there is no comprehensive summary of changes in neuroanatomical and electrophysiological properties in the so-called healthy hemisphere induced by unilateral lesion of the nigrostriatal dopaminergic system and its correlation to behavior.</p>
<p>Contralateral intrastriatal application of 1 ng BoNT-A in hemi-PD rats improved the use of the right paw in hemi-PD rats for up to 9 months both in the number of forehand and backhand steps. In this case, BoNT-A was injected into a seemingly normal transmitter and receptor environment. BoNT-A is thought to block the ACh release of cholinergic interneurons and DA release of dopaminergic afferents (Bigalke et al., <xref ref-type="bibr" rid="B11">1985</xref>; Ashton and Dolly, <xref ref-type="bibr" rid="B6">1988</xref>), perhaps also reduces the D2 receptor concentration. As a result, the MSN decreased the GABAergic innervation of the EGP, resulting in an increased inhibition of the spontaneously active STh and followed by a less actively firing IGP, which inhibits VL to a lesser degree than normally. Finally, the disinhibited VL neurons considerably activated the premotor cortex that in turn increased the initiation of movements of the contralateral body, i.e., the forelimb ipsilateral to the DA deprivation, via its crossed motor efferents. In the end, the paw of the DA deprived body side is hyperactive as compared to the sham-injected hemi-PD rats. As already supposed by Olsson et al. (<xref ref-type="bibr" rid="B103">1995</xref>) we observed an age dependent decline of right paw forehand and backhand steps, both in sham- and BoNT-A-injected rats up to 9 months, suggesting some degree of habituation to the test.</p>
</sec>
<sec id="s4-3-2">
<title>Cylinder Test</title>
<p>Unilateral right side hemi-PD rats exhibited a significantly reduced use of the left forelimb. Intrastriatal ipsilateral BoNT-A or sham treatment did not show any significant improvement of the left forelimb usage. Interestingly, contralateral intrastriatal injection of BoNT-A led to a short term (at test point 2 weeks after BoNT-A) significant readjustment of forepaw usage.</p>
<p>In the hemi-PD rats our results are in line with others (Schallert and Tillerson, <xref ref-type="bibr" rid="B122">2000</xref>; Kirik et al., <xref ref-type="bibr" rid="B77">2001</xref>; Deumens et al., <xref ref-type="bibr" rid="B42">2002</xref>; Cohen et al., <xref ref-type="bibr" rid="B29">2003</xref>; Vercammen et al., <xref ref-type="bibr" rid="B150">2006</xref>; Rauch et al., <xref ref-type="bibr" rid="B113">2010</xref>; de Ara&#x000FA;jo et al., <xref ref-type="bibr" rid="B37">2013</xref>), the impaired paw being relatively used by about 40% to 50% compared to the unimpaired. As for the stepping impairment the motor initiation deficit for voluntary movements in contralateral forelimb use is discussed as a result of DA depletion (Whishaw et al., <xref ref-type="bibr" rid="B154">1986</xref>; Lundblad et al., <xref ref-type="bibr" rid="B88">2002</xref>; Shi et al., <xref ref-type="bibr" rid="B135">2004</xref>; Schallert and Woodlee, <xref ref-type="bibr" rid="B123">2005</xref>; Wheeler et al., <xref ref-type="bibr" rid="B153">2014</xref>; Sampaio et al., <xref ref-type="bibr" rid="B120">2017</xref>). As dopaminergic deprivation of the striatum causes increased GABAergic MSN projection to the EGP, and via disinhibition of the spontaneously active STh a more actively firing IGP, the inhibited VL neurons do not sufficiently activate the premotor cortex. Consequently, there is a reduces initiation of movements of the contralateral body via its crossed motor efferents (Obeso et al., <xref ref-type="bibr" rid="B100">2008a</xref>,<xref ref-type="bibr" rid="B101">b</xref>, <xref ref-type="bibr" rid="B102">2014</xref>; Wree and Schmitt, <xref ref-type="bibr" rid="B157">2015</xref>).</p>
<p>Ipsilateral intrastriatal application of BoNT-A or sham injection in hemi-PD rats did not change the impairments. Our explanation resembles that of the stepping test. For the execution of the voluntary forelimb movements a normal DA content of the CPu is essential (Salamone et al., <xref ref-type="bibr" rid="B119">1993</xref>; Shi et al., <xref ref-type="bibr" rid="B135">2004</xref>; Manfredsson et al., <xref ref-type="bibr" rid="B92">2007</xref>; Woodlee et al., <xref ref-type="bibr" rid="B156">2008</xref>; Plowman et al., <xref ref-type="bibr" rid="B110">2011</xref>; Fleming et al., <xref ref-type="bibr" rid="B55">2013</xref>; Mabandla et al., <xref ref-type="bibr" rid="B89">2015</xref>). BoNT-A did not improve left forelimb use as it could increase DA concentration.</p>
<p>Contralateral intrastriatal application of 1 ng BoNT-A in hemi-PD rats shortly improved the use of the left paw in hemi-PD rats. Seemingly, BoNT-A for a limited time interacts with ACh release from cholinergic interneurons and DA release from dopaminergic afferents (Bigalke et al., <xref ref-type="bibr" rid="B11">1985</xref>; Ashton and Dolly, <xref ref-type="bibr" rid="B6">1988</xref>).</p>
</sec>
<sec id="s4-3-3">
<title>Open Field Test</title>
<p>Spontaneous horizontal locomotor activity and anxiety as measured by the OF test showed decreased locomotor activity in hemi-PD rats compared to prelesion results. Ipsilateral intrastriatal BoNT-A and sham injections neither changed total running distance nor the ratio of center distance to total distance significantly over time. Also contralateral intrastriatal BoNT-A or sham injection had a significant effect on locomotor activity of hemi-PD rats.</p>
<p>Unilateral 6-OHDA-injection decreased the overall spontaneous locomotor behavior as measured by total walking distance as already shown by others (Kirik et al., <xref ref-type="bibr" rid="B77">2001</xref>; Tam&#x000E1;s et al., <xref ref-type="bibr" rid="B139">2005</xref>; Brown et al., <xref ref-type="bibr" rid="B18">2011</xref>; Abedi et al., <xref ref-type="bibr" rid="B1">2013</xref>; Capper-Loup et al., <xref ref-type="bibr" rid="B21">2013</xref>; da Rocha et al., <xref ref-type="bibr" rid="B33">2013</xref>; Sun et al., <xref ref-type="bibr" rid="B137">2013</xref>; Machado-Filho et al., <xref ref-type="bibr" rid="B90">2014</xref>; Chao et al., <xref ref-type="bibr" rid="B26">2015</xref>; Kumari et al., <xref ref-type="bibr" rid="B82">2015</xref>; Ximenes et al., <xref ref-type="bibr" rid="B159">2015</xref>; Das et al., <xref ref-type="bibr" rid="B34">2016</xref>; Sgroi et al., <xref ref-type="bibr" rid="B133">2016</xref>). Reduced locomotion is tentatively interpreted as a result of depletion of striatal DA (Fearnley and Lees, <xref ref-type="bibr" rid="B51">1991</xref>; Schwarting and Huston, <xref ref-type="bibr" rid="B131">1996</xref>; Alam and Schmidt, <xref ref-type="bibr" rid="B2">2002</xref>; Ferro et al., <xref ref-type="bibr" rid="B53">2005</xref>; Carvalho et al., <xref ref-type="bibr" rid="B24">2013</xref>), although there is no clear explanation why a unilateral DA depletion has such a massive effect (about 50% reduction) on total walking distance as a measure of whole body bradykinesia of the hemi-PD rats. Additionally, we could not observe that the impairments of hemi-PD rats were age and habituation dependent. It has been previously reported that locomotor activity declined in aging hemi-PD rats (Schulz et al., <xref ref-type="bibr" rid="B129">2002</xref>, <xref ref-type="bibr" rid="B130">2004</xref>; Jezek et al., <xref ref-type="bibr" rid="B71">2003</xref>) or due to habituation (Gentsch et al., <xref ref-type="bibr" rid="B59">1982</xref>; Bure&#x00161; et al., <xref ref-type="bibr" rid="B20">1983</xref>) in OF.</p>
</sec>
<sec id="s4-3-4">
<title>Corridor Task</title>
<p>Naive rats equally retrieved pellets from either left or right sides. The right side 6-OHDA-lesion caused a massive neglect of the left corridor side. Ipsilateral intrastriatal BoNT-A did not improve contralateral sensorimotor integration up to 6 months significantly. In contrast, contralateral intrastriatal BoNT-A-injection significantly reversed this bias, and significant contralateral retrievals of about 40% were seen.</p>
<p>Anatomical, biochemical and behavioral evidence indicate that striatum is heterogeneous with respect to function (Divac et al., <xref ref-type="bibr" rid="B43">1967</xref>; Dunnett and Iversen, <xref ref-type="bibr" rid="B46">1980</xref>; Pisa, <xref ref-type="bibr" rid="B108">1988</xref>) and the intact nigrostriatal innervation is crucial for successful integration of sensory and motor function resulting in a coordinated goal-directed behavior (Turner, <xref ref-type="bibr" rid="B145">1973</xref>; Dunnett and Iversen, <xref ref-type="bibr" rid="B47">1982</xref>; Carli et al., <xref ref-type="bibr" rid="B22">1985</xref>, <xref ref-type="bibr" rid="B23">1989</xref>; Fairley and Marshall, <xref ref-type="bibr" rid="B49">1986</xref>). Thus, the corridor task is a sensitive behavioral test for unilateral 6-OHDA-lesion (Boix et al., <xref ref-type="bibr" rid="B14">2015</xref>) measuring the lateralized sensorimotor proprioception and neglect.</p>
<p>Unilateral striatal DA depletion results in a polymodal &#x0201C;neglect&#x0201D; characterized by a failure to orient to contralateral stimuli (Marshall et al., <xref ref-type="bibr" rid="B93">1971</xref>; Ljungberg and Ungerstedt, <xref ref-type="bibr" rid="B87">1976</xref>; Fairley and Marshall, <xref ref-type="bibr" rid="B49">1986</xref>; Brown et al., <xref ref-type="bibr" rid="B18">2011</xref>) and hemi-PD rats failed to orient to tactile, visual or olfactory stimuli presented on the contralateral side of the body (Dowd et al., <xref ref-type="bibr" rid="B45">2005</xref>). Respective abnormalities have already been reported in PD patients (Berardelli et al., <xref ref-type="bibr" rid="B9">2001</xref>). Brown and Robbins suggested that the &#x0201C;striatal neglect&#x0201D; was not due to a failure to localize the stimuli in contralateral space but, rather, resulted from a deficit in directing responses in contralateral space (Brown and Robbins, <xref ref-type="bibr" rid="B19">1989</xref>). Accordingly, Carli et al. (<xref ref-type="bibr" rid="B22">1985</xref>) stated that the neglect is not primarily sensory in nature but is evident only when a contralateral response initiation, in our experiments the retrieval of pellets, is required.</p>
<p>In our study naive animals made equivalent numbers (about 50%) of retrievals from both the left or right corridor sides as shown previously by others (Dowd et al., <xref ref-type="bibr" rid="B45">2005</xref>; Fitzsimmons et al., <xref ref-type="bibr" rid="B54">2006</xref>; D&#x000F6;br&#x000F6;ssy and Dunnett, <xref ref-type="bibr" rid="B44">2007</xref>; Kerkerian-Le Goff et al., <xref ref-type="bibr" rid="B75">2009</xref>; Jouve et al., <xref ref-type="bibr" rid="B72">2010</xref>). Hemi-PD rats largely neglect sugar pellets encountered on their contralateral side, demonstrating a pronounced ipsilateral retrieval bias (Torres et al., <xref ref-type="bibr" rid="B140">2008</xref>; Cordeiro et al., <xref ref-type="bibr" rid="B31">2010</xref>; Kaindlstorfer et al., <xref ref-type="bibr" rid="B73">2012</xref>; Naughton et al., <xref ref-type="bibr" rid="B98">2016</xref>). As discussed with stepping and cylinder tests, hemi-PD rats showed a severe impairment of motor initiation of the contralateral body including forelimbs and especially in head orientation. Although the hemi-PD rat seemingly detected the contralateral stimulus (sugar pellets in bowl), it could not react due to the impaired initiation, and, consequently, food pellets were retrieved by the unaltered paw of the opposite side. The motor initiation deficits in the forelimbs were discussed as caused by DA depletion (Sabol et al., <xref ref-type="bibr" rid="B118">1985</xref>; Fairley and Marshall, <xref ref-type="bibr" rid="B49">1986</xref>; Salamone et al., <xref ref-type="bibr" rid="B119">1993</xref>; Dowd et al., <xref ref-type="bibr" rid="B45">2005</xref>; Fitzsimmons et al., <xref ref-type="bibr" rid="B54">2006</xref>) with the known consequences in basal ganglia circuitry.</p>
<p>Intrastriatal ipsilateral BoNT-A-injection did not alter the striatal neglect in hemi-PD rats. This is not surprising, as the DA deficit underlying the neglect was not changed by BoNT-application.</p>
<p>As a key finding in the present study, we obtained a significantly positive effect of intrastriatal contralateral BoNT-A-injection on the contralateral neglect in hemi-PD rats. As discussed with the BoNT-induced changes in the stepping test, we have no comprehensive interpretation of the BoNT-induced behavioral benefit. Taken together, as the molecular mechanism underlying the jet unclear lesion-induced compensatory mechanisms in the hemisphere contralateral to the 6-OHDA-lesion is not further substantiated, we cannot explain the beneficial effect in the contralateral intrastriatal BoNT-application on spontaneous motor task of the hemi-PD rats.</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>As hypothesized, some of the behavioral effects seen after ipsilateral BoNT-A-application in hemi-PD rats were reversed or even changed to the opposite by contralateral BoNT-A-injection in hemi-PD rats.</p>
<p>In hemi-PD rats, intrastriatal ipsilateral BoNT-A-injection massively influenced the outcome of drug-induced tests. We found a significant decrease in apomorphine-induced rotations and an increase in amphetamine-induced rotations. Moreover, ipsilateral intrastriatal application of BoNT-A showed no effect on the forelimb usage and akinesia, lateralized sensorimotor integration and spontaneous locomotor activity.</p>
<p>However, contralateral intrastriatal BoNT-A-injection preferentially affected spontaneous motor behavior reducing striatal neglect, and also maintained a significant reduction of the akinesia in stepping test. Furthermore, contralateral intrastriatal application of BoNT-A exhibited a short influence on the apomorphine-induced rotations and led to a transient re-adjustment of right and left forepaw usage in cylinder test. Amphetamine-induced rotations and locomotor activity in OF test stayed unaltered after contralateral BoNT-A-injection.</p>
<p>These temporally restricted effects of BoNT-A-application suggest that intrastriatally applied BoNT-A acted not only as an inhibitor of ACh release but also had impact on transmitter receptors, especially D2 receptor expression and thereby on the basal ganglia circuitry. Evaluation of receptor concentrations of all important striatal transmitters are subject of ongoing studies of our group.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>CH, OS and AW designed the study. VAA, AW and AH performed experiments. CH did the statistics and the figures. VAA, CH, AW, OS and AH wrote the manuscript.</p>
</sec>
<sec id="s7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>The technical assistance of Susann Lehmann and Frauke Winzer is gratefully acknowledged.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> Rostock University Medical Center internal funding FORUN 889005 + 889014.</p>
</fn>
</fn-group>
<sec sec-type="supplementary material" id="s8">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00119/full&#x00023;supplementary-material">http://journal.frontiersin.org/article/10.3389/fnbeh.2017.00119/full&#x00023;supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abedi</surname> <given-names>P. M.</given-names></name> <name><surname>Delaville</surname> <given-names>C.</given-names></name> <name><surname>De Deurwaerd&#x000E8;re</surname> <given-names>P.</given-names></name> <name><surname>Benjelloun</surname> <given-names>W.</given-names></name> <name><surname>Benazzouz</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Intrapallidal administration of 6-hydroxydopamine mimics in large part the electrophysiological and behavioral consequences of major dopamine depletion in the rat</article-title>. <source>Neuroscience</source> <volume>236</volume>, <fpage>289</fpage>&#x02013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.01.043</pub-id><pub-id pub-id-type="pmid">23376117</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alam</surname> <given-names>M.</given-names></name> <name><surname>Schmidt</surname> <given-names>W. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats</article-title>. <source>Behav. Brain Res.</source> <volume>136</volume>, <fpage>317</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(02)00180-8</pub-id><pub-id pub-id-type="pmid">12385818</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andringa</surname> <given-names>G.</given-names></name> <name><surname>Van Oosten</surname> <given-names>R. V.</given-names></name> <name><surname>Unger</surname> <given-names>W.</given-names></name> <name><surname>Hafmans</surname> <given-names>T. G. M.</given-names></name> <name><surname>Veening</surname> <given-names>J.</given-names></name> <name><surname>Stoof</surname> <given-names>J. C.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Systemic administration of the propargylamine CGP 3466B prevents behavioural and morphological deficits in rats with 6-hydroxydopamine-induced lesions in the substantia nigra</article-title>. <source>Eur. J. Neurosci.</source> <volume>12</volume>, <fpage>3033</fpage>&#x02013;<lpage>3043</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00181.x</pub-id><pub-id pub-id-type="pmid">10971644</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antipova</surname> <given-names>V.</given-names></name> <name><surname>Hawlitschka</surname> <given-names>A.</given-names></name> <name><surname>Mix</surname> <given-names>E.</given-names></name> <name><surname>Schmitt</surname> <given-names>O.</given-names></name> <name><surname>Dr&#x000E4;ger</surname> <given-names>D.</given-names></name> <name><surname>Benecke</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Behavioral and structural effects of unilateral intrastriatal injections of botulinum neurotoxin a in the rat model of Parkinson&#x02019;s disease</article-title>. <source>J. Neurosci. Res.</source> <volume>91</volume>, <fpage>838</fpage>&#x02013;<lpage>847</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23210</pub-id><pub-id pub-id-type="pmid">23553727</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname> <given-names>T.</given-names></name> <name><surname>Tanji</surname> <given-names>H.</given-names></name> <name><surname>Kato</surname> <given-names>H.</given-names></name> <name><surname>Itoyama</surname> <given-names>Y.</given-names></name></person-group> (<year>1998</year>). <article-title>Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle</article-title>. <source>J. Neurol. Sci.</source> <volume>160</volume>, <fpage>121</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-510x(98)00248-2</pub-id><pub-id pub-id-type="pmid">9849794</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashton</surname> <given-names>A. C.</given-names></name> <name><surname>Dolly</surname> <given-names>J. O.</given-names></name></person-group> (<year>1988</year>). <article-title>Characterization of the inhibitory action of botulinum neurotoxin type A on the release of several transmitters from rat cerebrocortical synaptosomes</article-title>. <source>J. Neurochem.</source> <volume>50</volume>, <fpage>1808</fpage>&#x02013;<lpage>1816</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1988.tb02482.x</pub-id><pub-id pub-id-type="pmid">2897427</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bagga</surname> <given-names>P.</given-names></name> <name><surname>Chugani</surname> <given-names>A. N.</given-names></name> <name><surname>Patel</surname> <given-names>A. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotective effects of caffeine in MPTP model of Parkinson&#x02019;s disease: a <sup>13</sup>C NMR study</article-title>. <source>Neurochem. Int.</source> <volume>92</volume>, <fpage>25</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2015.11.006</pub-id><pub-id pub-id-type="pmid">26626997</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bargiotas</surname> <given-names>P.</given-names></name> <name><surname>Konitsiotis</surname> <given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Levodopa-induced dyskinesias in Parkinson&#x02019;s disease: emerging treatments</article-title>. <source>Neuropsychiatr. Dis. Treat.</source> <volume>9</volume>, <fpage>1605</fpage>&#x02013;<lpage>1617</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S36693</pub-id><pub-id pub-id-type="pmid">24174877</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barn&#x000E9;oud</surname> <given-names>P.</given-names></name> <name><surname>Descombris</surname> <given-names>E.</given-names></name> <name><surname>Aubin</surname> <given-names>N.</given-names></name> <name><surname>Abrous</surname> <given-names>D. N.</given-names></name></person-group> (<year>2000</year>). <article-title>Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system</article-title>. <source>Eur. J. Neurosci.</source> <volume>12</volume>, <fpage>322</fpage>&#x02013;<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00896.x</pub-id><pub-id pub-id-type="pmid">10651887</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berardelli</surname> <given-names>A.</given-names></name> <name><surname>Rothwell</surname> <given-names>J. C.</given-names></name> <name><surname>Thompson</surname> <given-names>P. D.</given-names></name> <name><surname>Hallett</surname> <given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Pathophysiology of bradykinesia in Parkinson&#x02019;s disease</article-title>. <source>Brain</source> <volume>124</volume>, <fpage>2131</fpage>&#x02013;<lpage>2146</lpage>. <pub-id pub-id-type="doi">10.1093/brain/124.11.2131</pub-id><pub-id pub-id-type="pmid">11673316</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berendse</surname> <given-names>H. W.</given-names></name> <name><surname>Graaf</surname> <given-names>Y. G.-D.</given-names></name> <name><surname>Groenewegen</surname> <given-names>H. J.</given-names></name></person-group> (<year>1992</year>). <article-title>Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat</article-title>. <source>J. Comp. Neurol.</source> <volume>316</volume>, <fpage>314</fpage>&#x02013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903160305</pub-id><pub-id pub-id-type="pmid">1577988</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bigalke</surname> <given-names>H.</given-names></name> <name><surname>Dreyer</surname> <given-names>F.</given-names></name> <name><surname>Bergey</surname> <given-names>G.</given-names></name></person-group> (<year>1985</year>). <article-title>Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture</article-title>. <source>Brain Res.</source> <volume>360</volume>, <fpage>318</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(85)91248-x</pub-id><pub-id pub-id-type="pmid">3000532</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blandini</surname> <given-names>F.</given-names></name> <name><surname>Armentero</surname> <given-names>M.-T.</given-names></name></person-group> (<year>2012</year>). <article-title>Animal models of Parkinson&#x02019;s disease</article-title>. <source>FEBS J.</source> <volume>279</volume>, <fpage>1156</fpage>&#x02013;<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08491.x</pub-id><pub-id pub-id-type="pmid">22251459</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blandini</surname> <given-names>F.</given-names></name> <name><surname>Nappi</surname> <given-names>G.</given-names></name> <name><surname>Tassorelli</surname> <given-names>C.</given-names></name> <name><surname>Martignoni</surname> <given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>Functional changes of the basal ganglia circuitry in Parkinson&#x02019;s disease</article-title>. <source>Prog. Neurobiol.</source> <volume>62</volume>, <fpage>63</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/s0301-0082(99)00067-2</pub-id><pub-id pub-id-type="pmid">10821982</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boix</surname> <given-names>J.</given-names></name> <name><surname>Padel</surname> <given-names>T.</given-names></name> <name><surname>Paul</surname> <given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>A partial lesion model of Parkinson&#x02019;s disease in mice&#x02014;Characterization of a 6-OHDA-induced medial forebrain bundle lesion</article-title>. <source>Behav. Brain Res.</source> <volume>284</volume>, <fpage>196</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.01.053</pub-id><pub-id pub-id-type="pmid">25698603</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bordia</surname> <given-names>T.</given-names></name> <name><surname>Zhang</surname> <given-names>D.</given-names></name> <name><surname>Perez</surname> <given-names>X. A.</given-names></name> <name><surname>Quik</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia</article-title>. <source>Exp. Neurol.</source> <volume>286</volume>, <fpage>32</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.09.009</pub-id><pub-id pub-id-type="pmid">27658674</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname> <given-names>H.</given-names></name> <name><surname>Del Tredici</surname> <given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Cortico-basal ganglia-cortical circuitry in Parkinson&#x02019;s disease reconsidered</article-title>. <source>Exp. Neurol.</source> <volume>212</volume>, <fpage>226</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.04.001</pub-id><pub-id pub-id-type="pmid">18501351</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braak</surname> <given-names>H.</given-names></name> <name><surname>Ghebremedhin</surname> <given-names>E.</given-names></name> <name><surname>R&#x000FC;b</surname> <given-names>U.</given-names></name> <name><surname>Bratzke</surname> <given-names>H.</given-names></name> <name><surname>Del Tredici</surname> <given-names>K.</given-names></name></person-group> (<year>2004</year>). <article-title>Stages in the development of Parkinson&#x02019;s disease-related pathology</article-title>. <source>Cell. Tissue Res.</source> <volume>318</volume>, <fpage>121</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-004-0956-9</pub-id><pub-id pub-id-type="pmid">15338272</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>A. R.</given-names></name> <name><surname>Antle</surname> <given-names>M. C.</given-names></name> <name><surname>Hu</surname> <given-names>B.</given-names></name> <name><surname>Teskey</surname> <given-names>G. C.</given-names></name></person-group> (<year>2011</year>). <article-title>High frequency stimulation of the subthalamic nucleus acutely rescues motor deficits and neocortical movement representations following 6-hydroxydopamine administration in rats</article-title>. <source>Exp. Neurol.</source> <volume>231</volume>, <fpage>82</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2011.05.017</pub-id><pub-id pub-id-type="pmid">21683073</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>V. J.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name></person-group> (<year>1989</year>). <article-title>Deficits in response space following unilateral striatal dopamine depletion in the rat</article-title>. <source>J. Neurosci.</source> <volume>9</volume>, <fpage>983</fpage>&#x02013;<lpage>989</lpage>. <pub-id pub-id-type="pmid">2926488</pub-id></citation></ref>
<ref id="B20"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Bure&#x00161;</surname> <given-names>J.</given-names></name> <name><surname>Bure&#x00161;ov&#x000E1;</surname> <given-names>O.</given-names></name> <name><surname>Huston</surname> <given-names>J.</given-names></name></person-group> (<year>1983</year>). <source>Techniques and Basic Experiments for the Study of Brain and Behavior.</source> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Science Publishers</publisher-name>.</citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Capper-Loup</surname> <given-names>C.</given-names></name> <name><surname>Frey</surname> <given-names>C. M.</given-names></name> <name><surname>Rebell</surname> <given-names>D.</given-names></name> <name><surname>Kaelin-Lang</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Adaptive gene expression changes on the healthy side of parkinsonian rats</article-title>. <source>Neuroscience</source> <volume>233</volume>, <fpage>157</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.12.027</pub-id><pub-id pub-id-type="pmid">23270858</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carli</surname> <given-names>M.</given-names></name> <name><surname>Evenden</surname> <given-names>J. L.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name></person-group> (<year>1985</year>). <article-title>Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention</article-title>. <source>Nature</source> <volume>313</volume>, <fpage>679</fpage>&#x02013;<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1038/313679a0</pub-id><pub-id pub-id-type="pmid">3974701</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carli</surname> <given-names>M.</given-names></name> <name><surname>Jones</surname> <given-names>G. H.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name></person-group> (<year>1989</year>). <article-title>Effects of unilateral dorsal and ventral striatal dopamine depletion on visual neglect in the rat: a neural and behavioural analysis</article-title>. <source>Neuroscience</source> <volume>29</volume>, <fpage>309</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(89)90059-6</pub-id><pub-id pub-id-type="pmid">2498760</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname> <given-names>M. M.</given-names></name> <name><surname>Campos</surname> <given-names>F. L.</given-names></name> <name><surname>Coimbra</surname> <given-names>B.</given-names></name> <name><surname>P&#x000EA;go</surname> <given-names>J. M.</given-names></name> <name><surname>Rodrigues</surname> <given-names>C.</given-names></name> <name><surname>Lima</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Behavioral characterization of the 6-hydroxidopamine model of Parkinson&#x02019;s disease and pharmacological rescuing of non-motor deficits</article-title>. <source>Mol. Neurodegener.</source> <volume>8</volume>:<fpage>14</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-8-14</pub-id><pub-id pub-id-type="pmid">23621954</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>J. W.</given-names></name> <name><surname>Wachtel</surname> <given-names>S. R.</given-names></name> <name><surname>Young</surname> <given-names>D.</given-names></name> <name><surname>Kang</surname> <given-names>U. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson&#x02019;s disease: Studies on medial forebrain bundle and striatal lesions</article-title>. <source>Neuroscience</source> <volume>88</volume>, <fpage>617</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(98)00217-6</pub-id><pub-id pub-id-type="pmid">10197780</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname> <given-names>O. Y.</given-names></name> <name><surname>Wang</surname> <given-names>A. L.</given-names></name> <name><surname>Nikolaus</surname> <given-names>S.</given-names></name> <name><surname>de Souza Silva</surname> <given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>NK<sub>3</sub> receptor agonism reinstates temporal order memory in the hemiparkinsonian rat</article-title>. <source>Behav. Brain Res.</source> <volume>285</volume>, <fpage>208</fpage>&#x02013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.06.006</pub-id><pub-id pub-id-type="pmid">24928770</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname> <given-names>J. Y.</given-names></name> <name><surname>Kim</surname> <given-names>C. H.</given-names></name> <name><surname>Jeon</surname> <given-names>T. J.</given-names></name> <name><surname>Cho</surname> <given-names>W. G.</given-names></name> <name><surname>Lee</surname> <given-names>J. S.</given-names></name> <name><surname>Lee</surname> <given-names>S. J.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains <italic>in vivo</italic> using consecutive PET scans of [<sup>18</sup>F]FPCIT and [<sup>18</sup>F]fallypride</article-title>. <source>Appl. Radiat. Isot.</source> <volume>70</volume>, <fpage>2689</fpage>&#x02013;<lpage>2694</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2012.08.005</pub-id><pub-id pub-id-type="pmid">23041777</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname> <given-names>C. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Medical management of Parkinson&#x02019;s disease</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>72</volume>, <fpage>I22</fpage>&#x02013;<lpage>I27</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.72.suppl_1.i22</pub-id><pub-id pub-id-type="pmid">11870200</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>A. D.</given-names></name> <name><surname>Tillerson</surname> <given-names>J. L.</given-names></name> <name><surname>Smith</surname> <given-names>A. D.</given-names></name> <name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>Zigmond</surname> <given-names>M. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF</article-title>. <source>J. Neurochem.</source> <volume>85</volume>, <fpage>299</fpage>&#x02013;<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01657.x</pub-id><pub-id pub-id-type="pmid">12675906</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Connolly</surname> <given-names>B. S.</given-names></name> <name><surname>Lang</surname> <given-names>A. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Pharmacological treatment of Parkinson disease: a review</article-title>. <source>JAMA</source> <volume>311</volume>, <fpage>1670</fpage>&#x02013;<lpage>1683</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2014.3654</pub-id><pub-id pub-id-type="pmid">24756517</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname> <given-names>K. K.</given-names></name> <name><surname>Jiang</surname> <given-names>W.</given-names></name> <name><surname>Papazoglou</surname> <given-names>A.</given-names></name> <name><surname>Ten&#x000F3;rio</surname> <given-names>S. B.</given-names></name> <name><surname>D&#x000F6;br&#x000F6;ssy</surname> <given-names>M.</given-names></name> <name><surname>Nikkhah</surname> <given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Graft-mediated functional recovery on a skilled forelimb use paradigm in a rodent model of Parkinson&#x02019;s disease is dependent on reward contingency</article-title>. <source>Behav. Brain Res.</source> <volume>212</volume>, <fpage>187</fpage>&#x02013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.04.012</pub-id><pub-id pub-id-type="pmid">20394782</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Creese</surname> <given-names>I.</given-names></name> <name><surname>Burt</surname> <given-names>D. R.</given-names></name> <name><surname>Snyder</surname> <given-names>S. H.</given-names></name></person-group> (<year>1977</year>). <article-title>Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity</article-title>. <source>Science</source> <volume>197</volume>, <fpage>596</fpage>&#x02013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1126/science.877576</pub-id><pub-id pub-id-type="pmid">877576</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>da Rocha</surname> <given-names>J. T.</given-names></name> <name><surname>Pinton</surname> <given-names>S.</given-names></name> <name><surname>Gai</surname> <given-names>B. M.</given-names></name> <name><surname>Nogueira</surname> <given-names>C. W.</given-names></name></person-group> (<year>2013</year>). <article-title>Diphenyl diselenide reduces mechanical and thermal nociceptive behavioral responses after unilateral intrastriatal administration of 6-hydroxydopamine in rats</article-title>. <source>Biol. Trace Elem. Res.</source> <volume>154</volume>, <fpage>372</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1007/s12011-013-9736-2</pub-id><pub-id pub-id-type="pmid">23821314</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Das</surname> <given-names>S. K.</given-names></name> <name><surname>Patel</surname> <given-names>B.</given-names></name> <name><surname>Patri</surname> <given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Neurotoxic effect of benzo[a]pyrene and its possible association with 6-hydroxydopamine induced neurobehavioral changes during early adolescence period in rats</article-title>. <source>J. Toxicol.</source> <volume>2016</volume>:<fpage>8606410</fpage>. <pub-id pub-id-type="doi">10.1155/2016/8606410</pub-id><pub-id pub-id-type="pmid">27034665</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dauer</surname> <given-names>W.</given-names></name> <name><surname>Przedborski</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Parkinson&#x02019;s disease: mechanisms and models</article-title>. <source>Neuron</source> <volume>39</volume>, <fpage>889</fpage>&#x02013;<lpage>909</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00568-3</pub-id><pub-id pub-id-type="pmid">12971891</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Day</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Ding</surname> <given-names>J.</given-names></name> <name><surname>An</surname> <given-names>X.</given-names></name> <name><surname>Ingham</surname> <given-names>C. A.</given-names></name> <name><surname>Shering</surname> <given-names>A. F.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models</article-title>. <source>Nat. Neurosci.</source> <volume>9</volume>, <fpage>251</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1038/nn1632</pub-id><pub-id pub-id-type="pmid">16415865</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Ara&#x000FA;jo</surname> <given-names>D. P.</given-names></name> <name><surname>De Sousa</surname> <given-names>C. N. S.</given-names></name> <name><surname>Ara&#x000FA;jo</surname> <given-names>P. V. P.</given-names></name> <name><surname>Menezes</surname> <given-names>C. E.</given-names></name> <name><surname>Sousa Rodrigues</surname> <given-names>F. T.</given-names></name> <name><surname>Escudeiro</surname> <given-names>S. S.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Behavioral and neurochemical effects of &#x003B1;-lipoic acid in the model of parkinson&#x02019;s disease induced by unilateral stereotaxic injection of 6-ohda in rat</article-title>. <source>Evid. Based Complement. Alternat. Med.</source> <volume>2013</volume>:<fpage>571378</fpage>. <pub-id pub-id-type="doi">10.1155/2013/571378</pub-id><pub-id pub-id-type="pmid">24023579</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeBoer</surname> <given-names>P.</given-names></name> <name><surname>Abercrombie</surname> <given-names>E. D.</given-names></name> <name><surname>Heeringa</surname> <given-names>M.</given-names></name> <name><surname>Westerink</surname> <given-names>B. H.</given-names></name></person-group> (<year>1993</year>). <article-title>Differential effect of systemic administration of bromocriptine and L-DOPA on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats</article-title>. <source>Brain Res.</source> <volume>608</volume>, <fpage>198</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(93)91459-6</pub-id><pub-id pub-id-type="pmid">8495354</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeFries</surname> <given-names>J. C.</given-names></name> <name><surname>Hegmann</surname> <given-names>J. P.</given-names></name> <name><surname>Weir</surname> <given-names>M. W.</given-names></name></person-group> (<year>1966</year>). <article-title>Open-field behavior in mice: evidence for a major gene effect mediated by the visual system</article-title>. <source>Science</source> <volume>154</volume>, <fpage>1577</fpage>&#x02013;<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1126/science.154.3756.1577</pub-id><pub-id pub-id-type="pmid">5924928</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeLong</surname> <given-names>M. R.</given-names></name> <name><surname>Wichmann</surname> <given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Circuits and circuit disorders of the basal ganglia</article-title>. <source>Arch. Neurol.</source> <volume>64</volume>, <fpage>20</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.64.1.20</pub-id><pub-id pub-id-type="pmid">17210805</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denenberg</surname> <given-names>V. H.</given-names></name></person-group> (<year>1969</year>). <article-title>Open-field bheavior in the rat: what does it mean?</article-title> <source>Ann. N Y Acad. Sci.</source> <volume>159</volume>, <fpage>852</fpage>&#x02013;<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1969.tb12983.x</pub-id><pub-id pub-id-type="pmid">5260302</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deumens</surname> <given-names>R.</given-names></name> <name><surname>Blokland</surname> <given-names>A.</given-names></name> <name><surname>Prickaerts</surname> <given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Modeling Parkinson&#x02019;s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway</article-title>. <source>Exp. Neurol.</source> <volume>175</volume>, <fpage>303</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1006/exnr.2002.7891</pub-id><pub-id pub-id-type="pmid">12061862</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Divac</surname> <given-names>I.</given-names></name> <name><surname>Rosvold</surname> <given-names>H. E.</given-names></name> <name><surname>Szwarcbart</surname> <given-names>M. K.</given-names></name></person-group> (<year>1967</year>). <article-title>Behavioral effects of selective ablation of the caudate nucleus</article-title>. <source>J. Comp. Physiol. Psychol.</source> <volume>63</volume>, <fpage>184</fpage>&#x02013;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1037/h0024348</pub-id><pub-id pub-id-type="pmid">4963561</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x000F6;br&#x000F6;ssy</surname> <given-names>M. D.</given-names></name> <name><surname>Dunnett</surname> <given-names>S. B.</given-names></name></person-group> (<year>2007</year>). <article-title>The corridor task: striatal lesion effects and graft-mediated recovery in a model of Huntington&#x02019;s disease</article-title>. <source>Behav. Brain Res.</source> <volume>179</volume>, <fpage>326</fpage>&#x02013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2007.02.030</pub-id><pub-id pub-id-type="pmid">17383020</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dowd</surname> <given-names>E.</given-names></name> <name><surname>Monville</surname> <given-names>C.</given-names></name> <name><surname>Torres</surname> <given-names>E. M.</given-names></name> <name><surname>Dunnett</surname> <given-names>S. B.</given-names></name></person-group> (<year>2005</year>). <article-title>The corridor task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum</article-title>. <source>Brain Res. Bull.</source> <volume>68</volume>, <fpage>24</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2005.08.009</pub-id><pub-id pub-id-type="pmid">16325001</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunnett</surname> <given-names>S. B.</given-names></name> <name><surname>Iversen</surname> <given-names>S. D.</given-names></name></person-group> (<year>1980</year>). <article-title>Regulatory impairments following selective kainic acid lesions of the neostriatum</article-title>. <source>Behav. Brain Res.</source> <volume>1</volume>, <fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(80)80082-9</pub-id><pub-id pub-id-type="pmid">7259856</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunnett</surname> <given-names>S. B.</given-names></name> <name><surname>Iversen</surname> <given-names>S. D.</given-names></name></person-group> (<year>1982</year>). <article-title>Regulatory impairments following selective 6-OHDA lesions of the neostriatum</article-title>. <source>Behav. Brain Res.</source> <volume>4</volume>, <fpage>195</fpage>&#x02013;<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/0166-4328(82)90072-9</pub-id><pub-id pub-id-type="pmid">7059376</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eikelis</surname> <given-names>N.</given-names></name> <name><surname>Van Den Buuse</surname> <given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Cardiovascular responses to open-field stress in rats: sex differences and effects of gonadal hormones</article-title>. <source>Stress</source> <volume>3</volume>, <fpage>319</fpage>&#x02013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.3109/10253890009001137</pub-id><pub-id pub-id-type="pmid">11342397</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fairley</surname> <given-names>P. C.</given-names></name> <name><surname>Marshall</surname> <given-names>J. F.</given-names></name></person-group> (<year>1986</year>). <article-title>Dopamine in the lateral caudate-putamen of the rat is essential for somatosensory orientation</article-title>. <source>Behav. Neurosci.</source> <volume>100</volume>, <fpage>652</fpage>&#x02013;<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1037//0735-7044.100.5.652</pub-id><pub-id pub-id-type="pmid">3022766</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname> <given-names>X.</given-names></name> <name><surname>Sugiyama</surname> <given-names>K.</given-names></name> <name><surname>Akamine</surname> <given-names>S.</given-names></name> <name><surname>Sun</surname> <given-names>W.</given-names></name> <name><surname>Namba</surname> <given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>The different performance among motor tasks during the increasing current intensity of deep brain stimulation of the subthalamic nucleus in rats with different degrees of the unilateral striatal lesion</article-title>. <source>Neurosci. Lett.</source> <volume>480</volume>, <fpage>64</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.06.004</pub-id><pub-id pub-id-type="pmid">20573573</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fearnley</surname> <given-names>J. M.</given-names></name> <name><surname>Lees</surname> <given-names>A. J.</given-names></name></person-group> (<year>1991</year>). <article-title>Ageing and Parkinson&#x02019;s disease: substantia nigra regional selectivity</article-title>. <source>Brain</source> <volume>114</volume>, <fpage>2283</fpage>&#x02013;<lpage>2301</lpage>. <pub-id pub-id-type="doi">10.1093/brain/114.5.2283</pub-id><pub-id pub-id-type="pmid">1933245</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname> <given-names>H. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Updates in the medical management of Parkinson disease</article-title>. <source>Cleve. Clin. J. Med.</source> <volume>79</volume>, <fpage>28</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.3949/ccjm.78gr.11005</pub-id><pub-id pub-id-type="pmid">22219231</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferro</surname> <given-names>M. M.</given-names></name> <name><surname>Bellissimo</surname> <given-names>M. I.</given-names></name> <name><surname>Anselmo-Franci</surname> <given-names>J. A.</given-names></name> <name><surname>Angellucci</surname> <given-names>M. E. M.</given-names></name> <name><surname>Canteras</surname> <given-names>N. S.</given-names></name> <name><surname>Da Cunha</surname> <given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson&#x02019;s disease: histological, neurochemical, motor and memory alterations</article-title>. <source>J. Neurosci. Methods</source> <volume>148</volume>, <fpage>78</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2005.04.005</pub-id><pub-id pub-id-type="pmid">15939479</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fitzsimmons</surname> <given-names>D. F.</given-names></name> <name><surname>Moloney</surname> <given-names>T. C.</given-names></name> <name><surname>Dowd</surname> <given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Further validation of the corridor task for assessing deficit and recovery in the hemi-Parkinsonian rat: restoration of bilateral food retrieval by dopamine receptor agonism</article-title>. <source>Behav. Brain Res.</source> <volume>169</volume>, <fpage>352</fpage>&#x02013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2006.01.013</pub-id><pub-id pub-id-type="pmid">16488026</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname> <given-names>S. M.</given-names></name> <name><surname>Ekhator</surname> <given-names>O. R.</given-names></name> <name><surname>Ghisays</surname> <given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Assessment of sensorimotor function in mouse models of Parkinson&#x02019;s disease</article-title>. <source>J. Vis. Exp.</source> <volume>76</volume>:<fpage>e50303</fpage>. <pub-id pub-id-type="doi">10.3791/50303</pub-id><pub-id pub-id-type="pmid">23851663</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname> <given-names>M. E.</given-names></name> <name><surname>Mikhailova</surname> <given-names>M. A.</given-names></name> <name><surname>Bass</surname> <given-names>C. E.</given-names></name> <name><surname>Takmakov</surname> <given-names>P.</given-names></name> <name><surname>Gainetdinov</surname> <given-names>R. R.</given-names></name> <name><surname>Budygin</surname> <given-names>E. A.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Cross-hemispheric dopamine projections have functional significance</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>113</volume>, <fpage>6985</fpage>&#x02013;<lpage>6990</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1603629113</pub-id><pub-id pub-id-type="pmid">27298371</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallyas</surname> <given-names>F.</given-names></name></person-group> (<year>1971</year>). <article-title>A principle for silver staining of tissue elements by physical development</article-title>. <source>Acta Morphol. Acad. Sci. Hung.</source> <volume>19</volume>, <fpage>57</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="pmid">4107509</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gallyas</surname> <given-names>F.</given-names></name></person-group> (<year>1979</year>). <article-title>Silver staining of myelin by means of physical development</article-title>. <source>Neurol. Res.</source> <volume>1</volume>, <fpage>203</fpage>&#x02013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1080/01616412.1979.11739553</pub-id><pub-id pub-id-type="pmid">95356</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gentsch</surname> <given-names>C.</given-names></name> <name><surname>Lichtsteiner</surname> <given-names>M.</given-names></name> <name><surname>Feer</surname> <given-names>H.</given-names></name></person-group> (<year>1982</year>). <article-title>Behavioural comparisons between individually- and group-housed male rats: effects of novel environments and diurnal rhythm</article-title>. <source>Behav. Brain Res.</source> <volume>6</volume>, <fpage>93</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/0166-4328(82)90084-5</pub-id><pub-id pub-id-type="pmid">7126327</pub-id></citation></ref>
<ref id="B60"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gerfen</surname> <given-names>C. R.</given-names></name></person-group> (<year>1994</year>). &#x0201C;<article-title>Basal Ganglia</article-title>,&#x0201D; in <source>The Rat Nervous System</source>, ed. <person-group person-group-type="editor"><name><surname>Toga</surname> <given-names>A. W.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Academic</publisher-name>), <fpage>217</fpage>&#x02013;<lpage>227</lpage>.</citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grealish</surname> <given-names>S.</given-names></name> <name><surname>Mattsson</surname> <given-names>B.</given-names></name> <name><surname>Draxler</surname> <given-names>P.</given-names></name> <name><surname>Bj&#x000F6;rklund</surname> <given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson&#x02019;s disease</article-title>. <source>Eur. J. Neurosci.</source> <volume>31</volume>, <fpage>2266</fpage>&#x02013;<lpage>2278</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07265.x</pub-id><pub-id pub-id-type="pmid">20529122</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>C. S.</given-names></name></person-group> (<year>1934</year>). <article-title>Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality</article-title>. <source>J. Comp. Psychol.</source> <volume>18</volume>, <fpage>385</fpage>&#x02013;<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1037/h0071444</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname> <given-names>C.</given-names></name> <name><surname>Ballachey</surname> <given-names>E. L.</given-names></name></person-group> (<year>1932</year>). <article-title>A study of the rat&#x02019;s behavior in a field. A contribution to method in comparative psychology</article-title>. <source>Univ. Calif. Publ. Psychol.</source> <volume>6</volume>, <fpage>1</fpage>&#x02013;<lpage>12</lpage>.</citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hassler</surname> <given-names>R.</given-names></name> <name><surname>Haug</surname> <given-names>P.</given-names></name> <name><surname>Nitsch</surname> <given-names>C.</given-names></name> <name><surname>Kim</surname> <given-names>J. S.</given-names></name> <name><surname>Paik</surname> <given-names>K.</given-names></name></person-group> (<year>1982</year>). <article-title>Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines, and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific cortico-striatal transmitter</article-title>. <source>J. Neurochem.</source> <volume>38</volume>, <fpage>1087</fpage>&#x02013;<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1982.tb05352.x</pub-id><pub-id pub-id-type="pmid">6121000</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawlitschka</surname> <given-names>A.</given-names></name> <name><surname>Antipova</surname> <given-names>V.</given-names></name> <name><surname>Schmitt</surname> <given-names>O.</given-names></name> <name><surname>Witt</surname> <given-names>M.</given-names></name> <name><surname>Benecke</surname> <given-names>R.</given-names></name> <name><surname>Mix</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Intracerebrally applied botulinum neurotoxin in experimental neuroscience</article-title>. <source>Curr. Pharm. Biotechnol.</source> <volume>14</volume>, <fpage>124</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.2174/138920113804805331</pub-id><pub-id pub-id-type="pmid">23092264</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holzmann</surname> <given-names>C.</given-names></name> <name><surname>Dr&#x000E4;ger</surname> <given-names>D.</given-names></name> <name><surname>Mix</surname> <given-names>E.</given-names></name> <name><surname>Hawlitschka</surname> <given-names>A.</given-names></name> <name><surname>Antipova</surname> <given-names>V.</given-names></name> <name><surname>Benecke</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Effects of intrastriatal botulinum neurotoxin A on the behavior of Wistar rats</article-title>. <source>Behav. Brain Res.</source> <volume>234</volume>, <fpage>107</fpage>&#x02013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2012.06.008</pub-id><pub-id pub-id-type="pmid">22728288</pub-id></citation></ref>
<ref id="B67"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hornykiewicz</surname> <given-names>O.</given-names></name> <name><surname>Kish</surname> <given-names>S. J.</given-names></name></person-group> (<year>1987</year>). &#x0201C;<article-title>Biochemical pathophysiology of Parkinson&#x02019;s disease</article-title>,&#x0201D; in <source>Parkinson&#x02019;s Disease</source>, eds <person-group person-group-type="editor"><name><surname>Yahr</surname> <given-names>M.</given-names></name> <name><surname>Bergmann</surname> <given-names>K.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Raven Press</publisher-name>), <fpage>19</fpage>&#x02013;<lpage>34</lpage>.</citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horstink</surname> <given-names>M.</given-names></name> <name><surname>Tolosa</surname> <given-names>E.</given-names></name> <name><surname>Bonuccelli</surname> <given-names>U.</given-names></name> <name><surname>Deuschl</surname> <given-names>G.</given-names></name> <name><surname>Friedman</surname> <given-names>A.</given-names></name> <name><surname>Kanovsky</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Review of the therapeutic management of Parkinson&#x02019;s disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson&#x02019;s disease</article-title>. <source>Eur. J. Neurol.</source> <volume>13</volume>, <fpage>1170</fpage>&#x02013;<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2006.01547.x</pub-id><pub-id pub-id-type="pmid">17038031</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname> <given-names>M. J.</given-names></name> <name><surname>Jenner</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>What has been learnt from study of dopamine receptors in Parkinson&#x02019;s disease?</article-title> <source>Pharmacol. Ther.</source> <volume>111</volume>, <fpage>715</fpage>&#x02013;<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.12.001</pub-id><pub-id pub-id-type="pmid">16458973</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inan</surname> <given-names>S. Y.</given-names></name> <name><surname>Soner</surname> <given-names>B. C.</given-names></name> <name><surname>Sahin</surname> <given-names>A. S.</given-names></name></person-group> (<year>2016</year>). <article-title>Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson&#x02019;s disease</article-title>. <source>Metab. Brain Dis.</source> <volume>31</volume>, <fpage>849</fpage>&#x02013;<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-016-9820-3</pub-id><pub-id pub-id-type="pmid">26996632</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jezek</surname> <given-names>K.</given-names></name> <name><surname>Schulz</surname> <given-names>D.</given-names></name> <name><surname>De Souza Silva</surname> <given-names>M. A.</given-names></name> <name><surname>M&#x000FC;ller</surname> <given-names>H.-W.</given-names></name> <name><surname>Huston</surname> <given-names>J. P.</given-names></name> <name><surname>Hasen&#x000F6;hrl</surname> <given-names>R. U.</given-names></name></person-group> (<year>2003</year>). <article-title>Effects of chronic intraventricular infusion of heparin glycosaminoglycan on learning and brain acetylcholine parameters in aged rats</article-title>. <source>Behav. Brain Res.</source> <volume>147</volume>, <fpage>115</fpage>&#x02013;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(03)00138-4</pub-id><pub-id pub-id-type="pmid">14659577</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jouve</surname> <given-names>L.</given-names></name> <name><surname>Salin</surname> <given-names>P.</given-names></name> <name><surname>Melon</surname> <given-names>C.</given-names></name> <name><surname>Goff</surname> <given-names>L. K.-L.</given-names></name></person-group> (<year>2010</year>). <article-title>Deep brain stimulation of the center median-parafascicular complex of the thalamus has efficient anti-parkinsonian action associated with widespread cellular responses in the basal ganglia network in a rat model of Parkinson&#x02019;s disease</article-title>. <source>J. Neurosci.</source> <volume>30</volume>, <fpage>9919</fpage>&#x02013;<lpage>9928</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1404-10.2010</pub-id><pub-id pub-id-type="pmid">20660274</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaindlstorfer</surname> <given-names>C.</given-names></name> <name><surname>Garc&#x000ED;a</surname> <given-names>J.</given-names></name> <name><surname>Winkler</surname> <given-names>C.</given-names></name> <name><surname>Wenning</surname> <given-names>G. K.</given-names></name> <name><surname>Nikkhah</surname> <given-names>G.</given-names></name> <name><surname>D&#x000F6;br&#x000F6;ssy</surname> <given-names>M. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Behavioral and histological analysis of a partial double-lesion model of parkinson-variant multiple system atrophy</article-title>. <source>J. Neurosci. Res.</source> <volume>90</volume>, <fpage>1284</fpage>&#x02013;<lpage>1295</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23021</pub-id><pub-id pub-id-type="pmid">22488729</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelsey</surname> <given-names>J. E.</given-names></name> <name><surname>Mague</surname> <given-names>S. D.</given-names></name> <name><surname>Pijanowski</surname> <given-names>R. S.</given-names></name> <name><surname>Harris</surname> <given-names>R. C.</given-names></name> <name><surname>Kleckner</surname> <given-names>N. W.</given-names></name> <name><surname>Matthews</surname> <given-names>R. T.</given-names></name></person-group> (<year>2004</year>). <article-title>NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats</article-title>. <source>Psychopharmacology</source> <volume>175</volume>, <fpage>179</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-004-1799-5</pub-id><pub-id pub-id-type="pmid">15007533</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerkerian-Le Goff</surname> <given-names>L.</given-names></name> <name><surname>Jouve</surname> <given-names>L.</given-names></name> <name><surname>Melon</surname> <given-names>C.</given-names></name> <name><surname>Salin</surname> <given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Rationale for targeting the thalamic centre-median parafascicular complex in the surgical treatment of Parkinson&#x02019;s disease</article-title>. <source>Parkinsonism Relat. Disord.</source> <volume>15</volume>, <fpage>S167</fpage>&#x02013;<lpage>S170</lpage>. <pub-id pub-id-type="doi">10.1016/s1353-8020(09)70807-7</pub-id><pub-id pub-id-type="pmid">20082982</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>H. D.</given-names></name> <name><surname>Jeong</surname> <given-names>K. H.</given-names></name> <name><surname>Jung</surname> <given-names>U. J.</given-names></name> <name><surname>Kim</surname> <given-names>S. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Myricitrin ameliorates 6-hydroxydopamine-induced dopaminergic neuronal loss in the substantia nigra of mouse brain</article-title>. <source>J. Med. Food</source> <volume>19</volume>, <fpage>374</fpage>&#x02013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2015.3581</pub-id><pub-id pub-id-type="pmid">26991235</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirik</surname> <given-names>D.</given-names></name> <name><surname>Winkler</surname> <given-names>C.</given-names></name> <name><surname>Bj&#x000F6;rklund</surname> <given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration</article-title>. <source>J. Neurosci.</source> <volume>21</volume>, <fpage>2889</fpage>&#x02013;<lpage>2896</lpage>. <pub-id pub-id-type="pmid">11306640</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klockgether</surname> <given-names>T.</given-names></name></person-group> (<year>2003</year>). <article-title>Medikament&#x000F6;se behandlung der idiopathischen Parkinson-krankheit</article-title>. <source>Nervenarzt</source> <volume>74</volume>, <fpage>S12</fpage>&#x02013;<lpage>S21</lpage>. <pub-id pub-id-type="doi">10.1007/s00115-003-1483-8</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Konieczny</surname> <given-names>J.</given-names></name> <name><surname>Czarnecka</surname> <given-names>A.</given-names></name> <name><surname>Lenda</surname> <given-names>T.</given-names></name> <name><surname>Kami&#x00144;ska</surname> <given-names>K.</given-names></name> <name><surname>Antkiewicz-Michaluk</surname> <given-names>L.</given-names></name></person-group> (<year>2017</year>). <article-title>The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: a comparative study of lactacystin and 6-OHDA</article-title>. <source>Neuroscience</source> <volume>340</volume>, <fpage>308</fpage>&#x02013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2016.10.070</pub-id><pub-id pub-id-type="pmid">27826109</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kortekaas</surname> <given-names>R.</given-names></name> <name><surname>Leenders</surname> <given-names>K. L.</given-names></name> <name><surname>van Oostrom</surname> <given-names>J. C. H.</given-names></name> <name><surname>Vaalburg</surname> <given-names>W.</given-names></name> <name><surname>Bart</surname> <given-names>J.</given-names></name> <name><surname>Willemsen</surname> <given-names>A. T. M.</given-names></name> <etal/></person-group>. (<year>2005</year>). <article-title>Blood-brain barrier dysfunction in parkinsonian midbrain <italic>in vivo</italic></article-title>. <source>Ann. Neurol.</source> <volume>57</volume>, <fpage>176</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20369</pub-id><pub-id pub-id-type="pmid">15668963</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumari</surname> <given-names>R.</given-names></name> <name><surname>Kumar</surname> <given-names>J. B. S.</given-names></name> <name><surname>Luthra</surname> <given-names>P. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson&#x02019;s disease</article-title>. <source>Neurosci. Lett.</source> <volume>589</volume>, <fpage>191</fpage>&#x02013;<lpage>195</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2014.12.030</pub-id><pub-id pub-id-type="pmid">25528406</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawler</surname> <given-names>C. P.</given-names></name> <name><surname>Gilmore</surname> <given-names>J. H.</given-names></name> <name><surname>Watts</surname> <given-names>V. J.</given-names></name> <name><surname>Walker</surname> <given-names>Q. D.</given-names></name> <name><surname>Southerland</surname> <given-names>S. B.</given-names></name> <name><surname>Cook</surname> <given-names>L. L.</given-names></name> <etal/></person-group>. (<year>1995</year>). <article-title>Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model</article-title>. <source>Synapse</source> <volume>21</volume>, <fpage>299</fpage>&#x02013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1002/syn.890210404</pub-id><pub-id pub-id-type="pmid">8869160</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lieu</surname> <given-names>C. A.</given-names></name> <name><surname>Subramanian</surname> <given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>The interhemispheric connections of the striatum: implications for Parkinson&#x02019;s disease and drug-induced dyskinesias</article-title>. <source>Brain Res. Bull.</source> <volume>87</volume>, <fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.09.013</pub-id><pub-id pub-id-type="pmid">21963946</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>S. A. O.</given-names></name> <name><surname>Kang</surname> <given-names>U. J.</given-names></name> <name><surname>McGehee</surname> <given-names>D. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Striatal cholinergic interneuron regulation and circuit effects</article-title>. <source>Front. Synaptic Neurosci.</source> <volume>6</volume>:<fpage>22</fpage>. <pub-id pub-id-type="doi">10.3389/fnsyn.2014.00022</pub-id><pub-id pub-id-type="pmid">25374536</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname> <given-names>M. D.</given-names></name> <name><surname>Plone</surname> <given-names>M. A.</given-names></name> <name><surname>Francis</surname> <given-names>J. M.</given-names></name> <name><surname>Blaney</surname> <given-names>T. J.</given-names></name> <name><surname>Salamone</surname> <given-names>J. D.</given-names></name> <name><surname>Emerich</surname> <given-names>D. F.</given-names></name></person-group> (<year>1997</year>). <article-title>Rats with partial striatal dopamine depletions exhibit robust and long-lasting behavioral deficits in a simple fixed-ratio bar-pressing task</article-title>. <source>Behav. Brain Res.</source> <volume>86</volume>, <fpage>25</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-4328(96)02240-1</pub-id><pub-id pub-id-type="pmid">9105579</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ljungberg</surname> <given-names>T.</given-names></name> <name><surname>Ungerstedt</surname> <given-names>U.</given-names></name></person-group> (<year>1976</year>). <article-title>Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain</article-title>. <source>Exp. Neurol.</source> <volume>53</volume>, <fpage>585</fpage>&#x02013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1016/0014-4886(76)90140-0</pub-id><pub-id pub-id-type="pmid">1001389</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lundblad</surname> <given-names>M.</given-names></name> <name><surname>Andersson</surname> <given-names>M.</given-names></name> <name><surname>Winkler</surname> <given-names>C.</given-names></name> <name><surname>Kirik</surname> <given-names>D.</given-names></name> <name><surname>Wierup</surname> <given-names>N.</given-names></name> <name><surname>Cenci Nilsson</surname> <given-names>M. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson&#x02019;s disease</article-title>. <source>Eur. J. Neurosci.</source> <volume>15</volume>, <fpage>120</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1046/j.0953-816x.2001.01843.x</pub-id><pub-id pub-id-type="pmid">11860512</pub-id></citation></ref>
<ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mabandla</surname> <given-names>M. V.</given-names></name> <name><surname>Nyoka</surname> <given-names>M.</given-names></name> <name><surname>Daniels</surname> <given-names>W. M. U.</given-names></name></person-group> (<year>2015</year>). <article-title>Early use of oleanolic acid provides protection against 6-hydroxydopamine induced dopamine neurodegeneration</article-title>. <source>Brain Res.</source> <volume>1622</volume>, <fpage>64</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.06.017</pub-id><pub-id pub-id-type="pmid">26111646</pub-id></citation></ref>
<ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Machado-Filho</surname> <given-names>J. A.</given-names></name> <name><surname>Correia</surname> <given-names>A. O.</given-names></name> <name><surname>Montenegro</surname> <given-names>A. B. A.</given-names></name> <name><surname>Nobre</surname> <given-names>M. E. P.</given-names></name> <name><surname>Cerqueira</surname> <given-names>G. S.</given-names></name> <name><surname>Neves</surname> <given-names>K. R. T.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions</article-title>. <source>Behav. Brain Res.</source> <volume>264</volume>, <fpage>116</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.01.051</pub-id><pub-id pub-id-type="pmid">24525422</pub-id></citation></ref>
<ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mamaligas</surname> <given-names>A. A.</given-names></name> <name><surname>Cai</surname> <given-names>Y.</given-names></name> <name><surname>Ford</surname> <given-names>C. P.</given-names></name></person-group> (<year>2016</year>). <article-title>Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>37834</fpage>. <pub-id pub-id-type="doi">10.1038/srep37834</pub-id><pub-id pub-id-type="pmid">27886263</pub-id></citation></ref>
<ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manfredsson</surname> <given-names>F. P.</given-names></name> <name><surname>Burger</surname> <given-names>C.</given-names></name> <name><surname>Sullivan</surname> <given-names>L. F.</given-names></name> <name><surname>Muzyczka</surname> <given-names>N.</given-names></name> <name><surname>Lewin</surname> <given-names>A. S.</given-names></name> <name><surname>Mandel</surname> <given-names>R. J.</given-names></name></person-group> (<year>2007</year>). <article-title>rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson&#x02019;s disease</article-title>. <source>Exp. Neurol.</source> <volume>207</volume>, <fpage>289</fpage>&#x02013;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2007.06.019</pub-id><pub-id pub-id-type="pmid">17678648</pub-id></citation></ref>
<ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname> <given-names>J. F.</given-names></name> <name><surname>Turner</surname> <given-names>B. H.</given-names></name> <name><surname>Teitelbaum</surname> <given-names>P.</given-names></name></person-group> (<year>1971</year>). <article-title>Sensory neglect produced by lateral hypothalamic damage</article-title>. <source>Science</source> <volume>174</volume>, <fpage>523</fpage>&#x02013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1126/science.174.4008.523</pub-id><pub-id pub-id-type="pmid">5165007</pub-id></citation></ref>
<ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mehlan</surname> <given-names>J.</given-names></name> <name><surname>Brosig</surname> <given-names>H.</given-names></name> <name><surname>Schmitt</surname> <given-names>O.</given-names></name> <name><surname>Mix</surname> <given-names>E.</given-names></name> <name><surname>Wree</surname> <given-names>A.</given-names></name> <name><surname>Hawlitschka</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Intrastriatal injection of botulinum neurotoxin-A is not cytotoxic in rat brain&#x02014;A histological and stereological analysis</article-title>. <source>Brain Res.</source> <volume>1630</volume>, <fpage>18</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.10.056</pub-id><pub-id pub-id-type="pmid">26562665</pub-id></citation></ref>
<ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meredith</surname> <given-names>G. E.</given-names></name> <name><surname>Sonsalla</surname> <given-names>P. K.</given-names></name> <name><surname>Chesselet</surname> <given-names>M.-F.</given-names></name></person-group> (<year>2008</year>). <article-title>Animal models of Parkinson&#x02019;s disease progression</article-title>. <source>Acta Neuropathol.</source> <volume>115</volume>, <fpage>385</fpage>&#x02013;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-008-0350-x</pub-id><pub-id pub-id-type="pmid">18273623</pub-id></citation></ref>
<ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merker</surname> <given-names>B.</given-names></name></person-group> (<year>1983</year>). <article-title>Silver staining of cell bodies by means of physical development</article-title>. <source>J. Neurosci. Methods</source> <volume>9</volume>, <fpage>235</fpage>&#x02013;<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/0165-0270(83)90086-9</pub-id><pub-id pub-id-type="pmid">6198563</pub-id></citation></ref>
<ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mukhida</surname> <given-names>K.</given-names></name> <name><surname>Baker</surname> <given-names>K. A.</given-names></name> <name><surname>Sadi</surname> <given-names>D.</given-names></name> <name><surname>Mendez</surname> <given-names>I.</given-names></name></person-group> (<year>2001</year>). <article-title>Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral, and intrasubthalamic nucleus dopaminergic transplants</article-title>. <source>J. Neurosci.</source> <volume>21</volume>, <fpage>3521</fpage>&#x02013;<lpage>3530</lpage>. <pub-id pub-id-type="pmid">11331381</pub-id></citation></ref>
<ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naughton</surname> <given-names>C.</given-names></name> <name><surname>Moriarty</surname> <given-names>N.</given-names></name> <name><surname>Feehan</surname> <given-names>J.</given-names></name> <name><surname>O&#x02019;Toole</surname> <given-names>D.</given-names></name> <name><surname>Dowd</surname> <given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson&#x02019;s disease</article-title>. <source>Behav. Brain Res.</source> <volume>296</volume>, <fpage>451</fpage>&#x02013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.09.025</pub-id><pub-id pub-id-type="pmid">26393432</pub-id></citation></ref>
<ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname> <given-names>D. E.</given-names></name> <name><surname>Frescas</surname> <given-names>S.</given-names></name> <name><surname>Marona-Lewicka</surname> <given-names>D.</given-names></name> <name><surname>Huang</surname> <given-names>X.</given-names></name> <name><surname>Roth</surname> <given-names>B. L.</given-names></name> <name><surname>Gudelsky</surname> <given-names>G. A.</given-names></name> <etal/></person-group>. (<year>1994</year>). <article-title>1&#x02013;(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist</article-title>. <source>J. Med. Chem.</source> <volume>37</volume>, <fpage>4346</fpage>&#x02013;<lpage>4351</lpage>. <pub-id pub-id-type="doi">10.1021/jm00051a011</pub-id><pub-id pub-id-type="pmid">7996545</pub-id></citation></ref>
<ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname> <given-names>J. A.</given-names></name> <name><surname>Marin</surname> <given-names>C.</given-names></name> <name><surname>Rodriguez-Oroz</surname> <given-names>C.</given-names></name> <name><surname>Blesa</surname> <given-names>J.</given-names></name> <name><surname>Benitez-Temi&#x000F1;o</surname> <given-names>B.</given-names></name> <name><surname>Mena-Segovia</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2008a</year>). <article-title>The basal ganglia in Parkinson&#x02019;s disease: current concepts and unexplained observations</article-title>. <source>Ann. Neurol.</source> <volume>64</volume>, <fpage>S30</fpage>&#x02013;<lpage>S46</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21481</pub-id><pub-id pub-id-type="pmid">19127584</pub-id></citation></ref>
<ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname> <given-names>J. A.</given-names></name> <name><surname>Rodr&#x000ED;guez-Oroz</surname> <given-names>M. C.</given-names></name> <name><surname>Benitez-Temino</surname> <given-names>B.</given-names></name> <name><surname>Blesa</surname> <given-names>F. J.</given-names></name> <name><surname>Guridi</surname> <given-names>J.</given-names></name> <name><surname>Marin</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2008b</year>). <article-title>Functional organization of the basal ganglia: therapeutic implications for Parkinson&#x02019;s disease</article-title>. <source>Mov. Disord.</source> <volume>23</volume>, <fpage>S548</fpage>&#x02013;<lpage>S559</lpage>. <pub-id pub-id-type="doi">10.1002/mds.22062</pub-id><pub-id pub-id-type="pmid">18781672</pub-id></citation></ref>
<ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname> <given-names>J. A.</given-names></name> <name><surname>Rodriguez-Oroz</surname> <given-names>M. C.</given-names></name> <name><surname>Stamelou</surname> <given-names>M.</given-names></name> <name><surname>Bhatia</surname> <given-names>K. P.</given-names></name> <name><surname>Burn</surname> <given-names>D. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The expanding universe of disorders of the basal ganglia</article-title>. <source>Lancet</source> <volume>384</volume>, <fpage>523</fpage>&#x02013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(13)62418-6</pub-id><pub-id pub-id-type="pmid">24954674</pub-id></citation></ref>
<ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname> <given-names>M.</given-names></name> <name><surname>Nikkhah</surname> <given-names>G.</given-names></name> <name><surname>Bentlage</surname> <given-names>C.</given-names></name> <name><surname>Bj&#x000F6;rklund</surname> <given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test</article-title>. <source>J. Neurosci.</source> <volume>15</volume>, <fpage>3863</fpage>&#x02013;<lpage>3875</lpage>. <pub-id pub-id-type="pmid">7751951</pub-id></citation></ref>
<ref id="B200"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname> <given-names>G.</given-names></name> <name><surname>Watson</surname> <given-names>C.</given-names></name></person-group> (<year>2007</year>). <source>The Rat Brain in Stereotaxic Coordinates</source>. <edition>6th Edn.</edition> <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Academic Press</publisher-name>.</citation></ref>
<ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelled</surname> <given-names>G.</given-names></name> <name><surname>Bergman</surname> <given-names>H.</given-names></name> <name><surname>Goelman</surname> <given-names>G.</given-names></name></person-group> (<year>2002</year>). <article-title>Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson&#x02019;s disease&#x02014;a functional magnetic resonance imaging study</article-title>. <source>Eur. J. Neurosci.</source> <volume>15</volume>, <fpage>389</fpage>&#x02013;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1046/j.0953-816x.2001.01866.x</pub-id><pub-id pub-id-type="pmid">11849305</pub-id></citation></ref>
<ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perreault</surname> <given-names>M. L.</given-names></name> <name><surname>Hasbi</surname> <given-names>A.</given-names></name> <name><surname>O&#x02019;Dowd</surname> <given-names>B. F.</given-names></name> <name><surname>George</surname> <given-names>S. R.</given-names></name></person-group> (<year>2011</year>). <article-title>The dopamine d1&#x02013;d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia</article-title>. <source>Front. Neuroanat.</source> <volume>5</volume>:<fpage>31</fpage>. <pub-id pub-id-type="doi">10.3389/fnana.2011.00031</pub-id><pub-id pub-id-type="pmid">21747759</pub-id></citation></ref>
<ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinna</surname> <given-names>A.</given-names></name> <name><surname>Tronci</surname> <given-names>E.</given-names></name> <name><surname>Schintu</surname> <given-names>N.</given-names></name> <name><surname>Simola</surname> <given-names>N.</given-names></name> <name><surname>Volpini</surname> <given-names>R.</given-names></name> <name><surname>Pontis</surname> <given-names>S.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>A new ethyladenine antagonist of adenosine A<sub>2A</sub> receptors: behavioral and biochemical characterization as an antiparkinsonian drug</article-title>. <source>Neuropharmacology</source> <volume>58</volume>, <fpage>613</fpage>&#x02013;<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.11.012</pub-id><pub-id pub-id-type="pmid">19951715</pub-id></citation></ref>
<ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pioli</surname> <given-names>E. Y.</given-names></name> <name><surname>Meissner</surname> <given-names>W.</given-names></name> <name><surname>Sohr</surname> <given-names>R.</given-names></name> <name><surname>Gross</surname> <given-names>C. E.</given-names></name> <name><surname>Bezard</surname> <given-names>E.</given-names></name> <name><surname>Bioulac</surname> <given-names>B. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Differential behavioral effects of partial bilateral lesions of ventral tegmental area or substantia nigra pars compacta in rats</article-title>. <source>Neuroscience</source> <volume>153</volume>, <fpage>1213</fpage>&#x02013;<lpage>1224</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.01.084</pub-id><pub-id pub-id-type="pmid">28577132</pub-id></citation></ref>
<ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pisa</surname> <given-names>M.</given-names></name></person-group> (<year>1988</year>). <article-title>Motor somatotopy in the striatum of rat: manipulation, biting and gait</article-title>. <source>Behav. Brain Res.</source> <volume>27</volume>, <fpage>21</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/0166-4328(88)90106-4</pub-id><pub-id pub-id-type="pmid">3342113</pub-id></citation></ref>
<ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pisani</surname> <given-names>A.</given-names></name> <name><surname>Bernardi</surname> <given-names>G.</given-names></name> <name><surname>Ding</surname> <given-names>J.</given-names></name> <name><surname>Surmeier</surname> <given-names>D. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Re-emergence of striatal cholinergic interneurons in movement disorders</article-title>. <source>Trends Neurosci.</source> <volume>30</volume>, <fpage>545</fpage>&#x02013;<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2007.07.008</pub-id><pub-id pub-id-type="pmid">17904652</pub-id></citation></ref>
<ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plowman</surname> <given-names>E. K.</given-names></name> <name><surname>Thomas</surname> <given-names>N. J.</given-names></name> <name><surname>Kleim</surname> <given-names>J. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Striatal dopamine depletion induces forelimb motor impairments and disrupts forelimb movement representations within the motor cortex</article-title>. <source>J. Parkinsons Dis.</source> <volume>1</volume>, <fpage>93</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.3233/JPD-2011-11017</pub-id><pub-id pub-id-type="pmid">23939260</pub-id></citation></ref>
<ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poulain</surname> <given-names>B.</given-names></name> <name><surname>Mochida</surname> <given-names>S.</given-names></name> <name><surname>Wadsworth</surname> <given-names>J. D.</given-names></name> <name><surname>Weller</surname> <given-names>U.</given-names></name> <name><surname>Habermann</surname> <given-names>E.</given-names></name> <name><surname>Dolly</surname> <given-names>J. O.</given-names></name> <etal/></person-group>. (<year>1990</year>). <article-title>Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains</article-title>. <source>J. Physiol.</source> <volume>84</volume>, <fpage>247</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="pmid">1981913</pub-id></citation></ref>
<ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quiroga-Varela</surname> <given-names>A.</given-names></name> <name><surname>Walters</surname> <given-names>J. R.</given-names></name> <name><surname>Brazhnik</surname> <given-names>E.</given-names></name> <name><surname>Marin</surname> <given-names>C.</given-names></name> <name><surname>Obeso</surname> <given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity</article-title>. <source>Neurobiol. Dis.</source> <volume>58</volume>, <fpage>242</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.05.010</pub-id><pub-id pub-id-type="pmid">23727447</pub-id></citation></ref>
<ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname> <given-names>F.</given-names></name> <name><surname>Schwabe</surname> <given-names>K.</given-names></name> <name><surname>Krauss</surname> <given-names>J. K.</given-names></name></person-group> (<year>2010</year>). <article-title>Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model</article-title>. <source>Behav. Brain Res.</source> <volume>210</volume>, <fpage>46</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.02.003</pub-id><pub-id pub-id-type="pmid">20138919</pub-id></citation></ref>
<ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reader</surname> <given-names>T. A.</given-names></name> <name><surname>Dewar</surname> <given-names>K. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: implications for human Parkinson&#x02019;s disease</article-title>. <source>Neurochem. Int.</source> <volume>34</volume>, <fpage>1</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/s0197-0186(98)00048-5</pub-id><pub-id pub-id-type="pmid">10100192</pub-id></citation></ref>
<ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname> <given-names>R.</given-names></name> <name><surname>Shi</surname> <given-names>C.</given-names></name> <name><surname>Cao</surname> <given-names>J.</given-names></name> <name><surname>Sun</surname> <given-names>Y.</given-names></name> <name><surname>Zhao</surname> <given-names>X.</given-names></name> <name><surname>Guo</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Neuroprotective effects of A standardized flavonoid extract of safflower against neurotoxin-induced cellular and animal models of Parkinson&#x02019;s disease</article-title>. <source>Sci. Rep.</source> <volume>6</volume>:<fpage>22135</fpage>. <pub-id pub-id-type="doi">10.1038/srep22135</pub-id><pub-id pub-id-type="pmid">26906725</pub-id></citation></ref>
<ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rico</surname> <given-names>A. J.</given-names></name> <name><surname>Dopeso-Reyes</surname> <given-names>I. G.</given-names></name> <name><surname>Mart&#x000ED;nez-Pinilla</surname> <given-names>E.</given-names></name> <name><surname>Sucunza</surname> <given-names>D.</given-names></name> <name><surname>Pignataro</surname> <given-names>D.</given-names></name> <name><surname>Roda</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Neurochemical evidence supporting dopamine D1&#x02013;D2 receptor heteromers in the striatum of the long-tailed macaque: changes following dopaminergic manipulation</article-title>. <source>Brain Struct. Funct.</source> <volume>222</volume>, <fpage>1767</fpage>&#x02013;<lpage>1784</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-016-1306-x</pub-id><pub-id pub-id-type="pmid">27612857</pub-id></citation></ref>
<ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritz</surname> <given-names>M. C.</given-names></name> <name><surname>Kuhar</surname> <given-names>M. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine</article-title>. <source>J. Pharmacol. Exp. Ther.</source> <volume>248</volume>, <fpage>1010</fpage>&#x02013;<lpage>1017</lpage>. <pub-id pub-id-type="pmid">2703961</pub-id></citation></ref>
<ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabol</surname> <given-names>K. E.</given-names></name> <name><surname>Neill</surname> <given-names>D. B.</given-names></name> <name><surname>Wages</surname> <given-names>S. A.</given-names></name> <name><surname>Church</surname> <given-names>W. H.</given-names></name> <name><surname>Justice</surname> <given-names>J. B.</given-names></name></person-group> (<year>1985</year>). <article-title>Dopamine depletion in a striatal subregion disrupts performance of a skilled motor task in the rat</article-title>. <source>Brain Res.</source> <volume>335</volume>, <fpage>33</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(85)90273-2</pub-id><pub-id pub-id-type="pmid">3924338</pub-id></citation></ref>
<ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salamone</surname> <given-names>J. D.</given-names></name> <name><surname>Kurth</surname> <given-names>P. A.</given-names></name> <name><surname>McCullough</surname> <given-names>L. D.</given-names></name> <name><surname>Sokolowski</surname> <given-names>J. D.</given-names></name> <name><surname>Cousins</surname> <given-names>M. S.</given-names></name></person-group> (<year>1993</year>). <article-title>The role of brain dopamine in response initiation: effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding</article-title>. <source>Brain Res.</source> <volume>628</volume>, <fpage>218</fpage>&#x02013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(93)90958-p</pub-id><pub-id pub-id-type="pmid">8313150</pub-id></citation></ref>
<ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sampaio</surname> <given-names>T. B.</given-names></name> <name><surname>Pinton</surname> <given-names>S.</given-names></name> <name><surname>da Rocha</surname> <given-names>J. T.</given-names></name> <name><surname>Gai</surname> <given-names>B. M.</given-names></name> <name><surname>Nogueira</surname> <given-names>C. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson&#x02019;s disease rat model</article-title>. <source>Eur. J. Pharmacol.</source> <volume>795</volume>, <fpage>28</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.11.054</pub-id><pub-id pub-id-type="pmid">27915043</pub-id></citation></ref>
<ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schackel</surname> <given-names>S.</given-names></name> <name><surname>Pauly</surname> <given-names>M.-C.</given-names></name> <name><surname>Piroth</surname> <given-names>T.</given-names></name> <name><surname>Nikkhah</surname> <given-names>G.</given-names></name> <name><surname>D&#x000F6;br&#x000F6;ssy</surname> <given-names>M. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Donor age dependent graft development and recovery in a rat model of Huntington&#x02019;s disease: histological and behavioral analysis</article-title>. <source>Behav. Brain Res.</source> <volume>256</volume>, <fpage>56</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2013.07.053</pub-id><pub-id pub-id-type="pmid">23916743</pub-id></citation></ref>
<ref id="B124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>De Ryck</surname> <given-names>M.</given-names></name> <name><surname>Whishaw</surname> <given-names>I. Q.</given-names></name> <name><surname>Ramirez</surname> <given-names>V. D.</given-names></name> <name><surname>Teitelbaum</surname> <given-names>P.</given-names></name></person-group> (<year>1979</year>). <article-title>Excessive bracing reactions and their control by atropine and L-DOPA in an animal analog of Parkinsonism</article-title>. <source>Exp. Neurol.</source> <volume>64</volume>, <fpage>33</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/0014-4886(79)90003-7</pub-id><pub-id pub-id-type="pmid">428497</pub-id></citation></ref>
<ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>Norton</surname> <given-names>D.</given-names></name> <name><surname>Jones</surname> <given-names>T. A.</given-names></name></person-group> (<year>1992</year>). <article-title>A clinically relevant unilateral rat model of Parkinsonian Akinesia</article-title>. <source>J. Neural Transplant. Plast.</source> <volume>3</volume>, <fpage>332</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1155/np.1992.332</pub-id></citation></ref>
<ref id="B122"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>Tillerson</surname> <given-names>J. L.</given-names></name></person-group> (<year>2000</year>). &#x0201C;<article-title>Intervention strategies for degeneration of dopamine neurons in parkinsonism: optimizing behavioral assessment of outcome</article-title>,&#x0201D; in <source>Central Nervous System Diseases</source>, eds <person-group person-group-type="editor"><name><surname>Emerich</surname> <given-names>D. F.</given-names></name> <name><surname>Dean</surname> <given-names>R. L.</given-names></name> <name><surname>Sanberg</surname> <given-names>P. R.</given-names></name></person-group> (<publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>131</fpage>&#x02013;<lpage>151</lpage>.</citation></ref>
<ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>Whishaw</surname> <given-names>I. Q.</given-names></name> <name><surname>Ramirez</surname> <given-names>V. D.</given-names></name> <name><surname>Teitelbaum</surname> <given-names>P.</given-names></name></person-group> (<year>1978</year>). <article-title>Compulsive, abnormal walking caused by anticholinergics in akinetic, 6-hydroxydopamine-treated rats</article-title>. <source>Science</source> <volume>199</volume>, <fpage>1461</fpage>&#x02013;<lpage>1463</lpage>. <pub-id pub-id-type="doi">10.1126/science.564552</pub-id><pub-id pub-id-type="pmid">564552</pub-id></citation></ref>
<ref id="B123"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>Woodlee</surname> <given-names>M. T.</given-names></name></person-group> (<year>2005</year>). &#x0201C;<article-title>Orienting and placing</article-title>,&#x0201D; in <source>The Behaviour of the Laboratory Rat: A Handbook with Tests</source>, eds <person-group person-group-type="editor"><name><surname>Whishaw</surname> <given-names>I. Q.</given-names></name> <name><surname>Kolb</surname> <given-names>B.</given-names></name></person-group> (<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>), <fpage>129</fpage>&#x02013;<lpage>135</lpage>.</citation></ref>
<ref id="B128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmitt</surname> <given-names>O.</given-names></name> <name><surname>Eipert</surname> <given-names>P.</given-names></name> <name><surname>Kettlitz</surname> <given-names>R.</given-names></name> <name><surname>Lessmann</surname> <given-names>F.</given-names></name> <name><surname>Wree</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>The connectome of the basal ganglia</article-title>. <source>Brain Struct. Funct.</source> <volume>221</volume>, <fpage>753</fpage>&#x02013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-014-0936-0</pub-id><pub-id pub-id-type="pmid">25432770</pub-id></citation></ref>
<ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>C. J.</given-names></name> <name><surname>Sullivan</surname> <given-names>C. K.</given-names></name> <name><surname>Fedayal</surname> <given-names>G. M.</given-names></name></person-group> (<year>1994</year>). <article-title>Blockade of striatal 5-hydroxytryptmine2 receptors reduces the increase in extracellullar concentrations of dopamine produced by the amphhetamine analogue 3,4-methylenedioxymethamphetamine</article-title>. <source>J. Neurochem.</source> <volume>62</volume>, <fpage>1382</fpage>&#x02013;<lpage>1389</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1994.62041382.x</pub-id><pub-id pub-id-type="pmid">7907650</pub-id></citation></ref>
<ref id="B129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>D.</given-names></name> <name><surname>Huston</surname> <given-names>J. P.</given-names></name> <name><surname>Jezek</surname> <given-names>K.</given-names></name> <name><surname>Haas</surname> <given-names>H. L.</given-names></name> <name><surname>Roth-H&#x000E4;rer</surname> <given-names>A.</given-names></name> <name><surname>Selbach</surname> <given-names>O.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Water maze performance, exploratory activity, inhibitory avoidance and hippocampal plasticity in aged superior and inferior learners</article-title>. <source>Eur. J. Neurosci.</source> <volume>16</volume>, <fpage>2175</fpage>&#x02013;<lpage>2185</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2002.02282.x</pub-id><pub-id pub-id-type="pmid">12473085</pub-id></citation></ref>
<ref id="B130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>D.</given-names></name> <name><surname>Sergeeva</surname> <given-names>O. A.</given-names></name> <name><surname>Ianovskii</surname> <given-names>E.</given-names></name> <name><surname>Luhmann</surname> <given-names>H. J.</given-names></name> <name><surname>Haas</surname> <given-names>H. L.</given-names></name> <name><surname>Huston</surname> <given-names>J. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Behavioural parameters in aged rats are related to LTP and gene expression of ChAT and NMDA-NR2 subunits in the striatum</article-title>. <source>Eur. J. Neurosci.</source> <volume>19</volume>, <fpage>1373</fpage>&#x02013;<lpage>1383</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03234.x</pub-id><pub-id pub-id-type="pmid">15016095</pub-id></citation></ref>
<ref id="B131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schwarting</surname> <given-names>R. K. W.</given-names></name> <name><surname>Huston</surname> <given-names>J. P.</given-names></name></person-group> (<year>1996</year>). <article-title>Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae</article-title>. <source>Prog. Neurobiol.</source> <volume>49</volume>, <fpage>215</fpage>&#x02013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/s0301-0082(96)00015-9</pub-id><pub-id pub-id-type="pmid">8878304</pub-id></citation></ref>
<ref id="B132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seeger-Armbruster</surname> <given-names>S.</given-names></name> <name><surname>von Ameln-Mayerhofer</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Short- and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons</article-title>. <source>Exp. Brain Res.</source> <volume>224</volume>, <fpage>15</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1007/s00221-012-3285-3</pub-id><pub-id pub-id-type="pmid">23283416</pub-id></citation></ref>
<ref id="B133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sgroi</surname> <given-names>S.</given-names></name> <name><surname>Capper-Loup</surname> <given-names>C.</given-names></name> <name><surname>Paganetti</surname> <given-names>P.</given-names></name> <name><surname>Kaelin-Lang</surname> <given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats</article-title>. <source>Exp. Neurol.</source> <volume>280</volume>, <fpage>80</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.03.024</pub-id><pub-id pub-id-type="pmid">27072528</pub-id></citation></ref>
<ref id="B134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shapovalova</surname> <given-names>K. B.</given-names></name></person-group> (<year>1995</year>). <article-title>Afferent and efferent mechanisms of the intensification of neostriatal cholinergic activity</article-title>. <source>Neurosci. Behav. Physiol.</source> <volume>25</volume>, <fpage>71</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1007/bf02359253</pub-id><pub-id pub-id-type="pmid">7777150</pub-id></citation></ref>
<ref id="B135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>L. H.</given-names></name> <name><surname>Woodward</surname> <given-names>D. J.</given-names></name> <name><surname>Luo</surname> <given-names>F.</given-names></name> <name><surname>Anstrom</surname> <given-names>K.</given-names></name> <name><surname>Schallert</surname> <given-names>T.</given-names></name> <name><surname>Chang</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2004</year>). <article-title>High-frequency stimulation of the subthalamic nucleus reverses limb-use asymmetry in rats with unilateral 6-hydroxydopamine lesions</article-title>. <source>Brain Res.</source> <volume>1013</volume>, <fpage>98</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2004.03.053</pub-id><pub-id pub-id-type="pmid">15196972</pub-id></citation></ref>
<ref id="B136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>E.</given-names></name> <name><surname>Rogers</surname> <given-names>J. T.</given-names></name> <name><surname>Devoto</surname> <given-names>P.</given-names></name> <name><surname>Bj&#x000F6;rklund</surname> <given-names>A.</given-names></name> <name><surname>Carta</surname> <given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson&#x02019;s disease</article-title>. <source>Exp. Neurol.</source> <volume>257</volume>, <fpage>25</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.04.011</pub-id><pub-id pub-id-type="pmid">24747357</pub-id></citation></ref>
<ref id="B137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>W.</given-names></name> <name><surname>Sugiyama</surname> <given-names>K.</given-names></name> <name><surname>Asakawa</surname> <given-names>T.</given-names></name> <name><surname>Ito-Yamashita</surname> <given-names>T.</given-names></name> <name><surname>Namba</surname> <given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Behavioral performance at early (4 weeks) and later (6 months) stages in rats with unilateral medial forebrain bundle and striatal 6-hydroxydopamine lesions</article-title>. <source>Neurol. Med. Chir. Tokyo.</source> <volume>53</volume>, <fpage>7</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.2176/nmc.53.7</pub-id><pub-id pub-id-type="pmid">23358162</pub-id></citation></ref>
<ref id="B138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sweeney</surname> <given-names>J. E.</given-names></name> <name><surname>Puttfarcken</surname> <given-names>P. S.</given-names></name> <name><surname>Coyle</surname> <given-names>J. T.</given-names></name></person-group> (<year>1989</year>). <article-title>Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice</article-title>. <source>Pharmacol. Biochem. Behav.</source> <volume>34</volume>, <fpage>129</fpage>&#x02013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/0091-3057(89)90364-x</pub-id><pub-id pub-id-type="pmid">2626444</pub-id></citation></ref>
<ref id="B139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tam&#x000E1;s</surname> <given-names>A.</given-names></name> <name><surname>Lubics</surname> <given-names>A.</given-names></name> <name><surname>Szalontay</surname> <given-names>L.</given-names></name> <name><surname>Lengv&#x000E1;ri</surname> <given-names>I.</given-names></name> <name><surname>Reglodi</surname> <given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats</article-title>. <source>Behav. Brain Res.</source> <volume>158</volume>, <fpage>221</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2004.09.002</pub-id><pub-id pub-id-type="pmid">15698888</pub-id></citation></ref>
<ref id="B140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname> <given-names>E. M.</given-names></name> <name><surname>Dowd</surname> <given-names>E.</given-names></name> <name><surname>Dunnett</surname> <given-names>S. B.</given-names></name></person-group> (<year>2008</year>). <article-title>Recovery of functional deficits following early donor age ventral mesencephalic grafts in a rat model of Parkinson&#x02019;s disease</article-title>. <source>Neuroscience</source> <volume>154</volume>, <fpage>631</fpage>&#x02013;<lpage>640</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.03.048</pub-id><pub-id pub-id-type="pmid">18468807</pub-id></citation></ref>
<ref id="B141"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tozzi</surname> <given-names>A.</given-names></name> <name><surname>de Iure</surname> <given-names>A.</given-names></name> <name><surname>Di Filippo</surname> <given-names>M.</given-names></name> <name><surname>Tantucci</surname> <given-names>M.</given-names></name> <name><surname>Costa</surname> <given-names>C.</given-names></name> <name><surname>Borsini</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>The distinct role of medium spiny neurons and cholinergic interneurons in the D<sub>2</sub>/A<sub>2</sub>A receptor interaction in the striatum: implications for Parkinson&#x02019;s disease</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>1850</fpage>&#x02013;<lpage>1862</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4082-10.2011</pub-id><pub-id pub-id-type="pmid">21289195</pub-id></citation></ref>
<ref id="B142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname> <given-names>L.</given-names></name> <name><surname>Worbe</surname> <given-names>Y.</given-names></name> <name><surname>Thobois</surname> <given-names>S.</given-names></name> <name><surname>Sgambato-Faure</surname> <given-names>V.</given-names></name> <name><surname>F&#x000E9;ger</surname> <given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders</article-title>. <source>Mov. Disord.</source> <volume>30</volume>, <fpage>1155</fpage>&#x02013;<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1002/mds.26199</pub-id><pub-id pub-id-type="pmid">25772380</pub-id></citation></ref>
<ref id="B143"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tronci</surname> <given-names>E.</given-names></name> <name><surname>Fidalgo</surname> <given-names>C.</given-names></name> <name><surname>Stancampiano</surname> <given-names>R.</given-names></name> <name><surname>Carta</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Effect of selective and non-selective serotonin receptor activation on L-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats</article-title>. <source>Behav. Brain Res.</source> <volume>292</volume>, <fpage>300</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.06.034</pub-id><pub-id pub-id-type="pmid">26119238</pub-id></citation></ref>
<ref id="B144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname> <given-names>K. Y.</given-names></name> <name><surname>Kargieman</surname> <given-names>L.</given-names></name> <name><surname>Gacio</surname> <given-names>S.</given-names></name> <name><surname>Riquelme</surname> <given-names>L. A.</given-names></name> <name><surname>Murer</surname> <given-names>M. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesia</article-title>. <source>Eur. J. Neurosci.</source> <volume>22</volume>, <fpage>2579</fpage>&#x02013;<lpage>2586</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04456.x</pub-id><pub-id pub-id-type="pmid">16307600</pub-id></citation></ref>
<ref id="B145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>B. H.</given-names></name></person-group> (<year>1973</year>). <article-title>Sensorimotor syndrome produced by lesions of the amygdala and lateral hypothalamus</article-title>. <source>J. Comp. Physiol. Psychol.</source> <volume>82</volume>, <fpage>37</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1037/h0033803</pub-id><pub-id pub-id-type="pmid">4567891</pub-id></citation></ref>
<ref id="B146"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungerstedt</surname> <given-names>U.</given-names></name></person-group> (<year>1968</year>). <article-title>6-hydroxy-dopamine induced degeneration of central monoamine neurons</article-title>. <source>Eur. J. Pharmacol.</source> <volume>5</volume>, <fpage>107</fpage>&#x02013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(68)90164-7</pub-id><pub-id pub-id-type="pmid">5718510</pub-id></citation></ref>
<ref id="B147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungerstedt</surname> <given-names>U.</given-names></name> <name><surname>Arbuthnott</surname> <given-names>G. W.</given-names></name></person-group> (<year>1970</year>). <article-title>Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</article-title>. <source>Brain Res.</source> <volume>24</volume>, <fpage>485</fpage>&#x02013;<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(70)90187-3</pub-id><pub-id pub-id-type="pmid">5494536</pub-id></citation></ref>
<ref id="B148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungerstedt</surname> <given-names>U.</given-names></name> <name><surname>Butcher</surname> <given-names>L. L.</given-names></name> <name><surname>Butcher</surname> <given-names>S. G.</given-names></name> <name><surname>Anden</surname> <given-names>N.-E.</given-names></name> <name><surname>Fuxe</surname> <given-names>K.</given-names></name></person-group> (<year>1969</year>). <article-title>Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat</article-title>. <source>Brain Res.</source> <volume>14</volume>, <fpage>461</fpage>&#x02013;<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(69)90122-x</pub-id><pub-id pub-id-type="pmid">4893861</pub-id></citation></ref>
<ref id="B149"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ungerstedt</surname> <given-names>U.</given-names></name> <name><surname>Ljungberg</surname> <given-names>T.</given-names></name> <name><surname>Steg</surname> <given-names>G.</given-names></name></person-group> (<year>1974</year>). <article-title>Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons</article-title>. <source>Adv. Neurol.</source> <volume>5</volume>, <fpage>421</fpage>&#x02013;<lpage>426</lpage>. <pub-id pub-id-type="pmid">4531217</pub-id></citation></ref>
<ref id="B150"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vercammen</surname> <given-names>L.</given-names></name> <name><surname>Van der Perren</surname> <given-names>A.</given-names></name> <name><surname>Vaudano</surname> <given-names>E.</given-names></name> <name><surname>Gijsbers</surname> <given-names>R.</given-names></name> <name><surname>Debyser</surname> <given-names>Z.</given-names></name> <name><surname>Van den Haute</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson&#x02019;s disease</article-title>. <source>Mol. Ther.</source> <volume>14</volume>, <fpage>716</fpage>&#x02013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2006.06.009</pub-id><pub-id pub-id-type="pmid">16914382</pub-id></citation></ref>
<ref id="B151"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Washbourne</surname> <given-names>P.</given-names></name> <name><surname>Pellizzari</surname> <given-names>R.</given-names></name> <name><surname>Rossetto</surname> <given-names>O.</given-names></name> <name><surname>Bortoletto</surname> <given-names>N.</given-names></name> <name><surname>Tugnoli</surname> <given-names>V.</given-names></name> <name><surname>De Grandis</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>1998</year>). <article-title>On the action of botulinum neurotoxins A and E at cholinergic terminals</article-title>. <source>J. Physiol. Paris</source> <volume>92</volume>, <fpage>135</fpage>&#x02013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/s0928-4257(98)80151-4</pub-id><pub-id pub-id-type="pmid">9782457</pub-id></citation></ref>
<ref id="B152"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinstock</surname> <given-names>M.</given-names></name> <name><surname>Poltyrev</surname> <given-names>T.</given-names></name> <name><surname>Bejar</surname> <given-names>C.</given-names></name> <name><surname>Youdim</surname> <given-names>M. B. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depression</article-title>. <source>Psychopharmacology</source> <volume>160</volume>, <fpage>318</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-001-0978-x</pub-id><pub-id pub-id-type="pmid">11889501</pub-id></citation></ref>
<ref id="B153"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname> <given-names>C. J.</given-names></name> <name><surname>Seksenyan</surname> <given-names>A.</given-names></name> <name><surname>Koronyo</surname> <given-names>Y.</given-names></name> <name><surname>Rentsendorj</surname> <given-names>A.</given-names></name> <name><surname>Sarayba</surname> <given-names>D.</given-names></name> <name><surname>Wu</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>T-lymphocyte deficiency exacerbates behavioral deficits in the 6-OHDA unilateral lesion rat model for Parkinson&#x02019;s disease</article-title>. <source>J. Neurol. Neurophysiol.</source> <volume>5</volume>:<fpage>209</fpage>. <pub-id pub-id-type="doi">10.4172/2155-9562.1000209</pub-id><pub-id pub-id-type="pmid">25346865</pub-id></citation></ref>
<ref id="B154"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whishaw</surname> <given-names>I. Q.</given-names></name> <name><surname>O&#x02019;Connor</surname> <given-names>W. T.</given-names></name> <name><surname>Dunnett</surname> <given-names>S. B.</given-names></name></person-group> (<year>1986</year>). <article-title>The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat</article-title>. <source>Brain</source> <volume>109</volume>, <fpage>805</fpage>&#x02013;<lpage>843</lpage>. <pub-id pub-id-type="doi">10.1093/brain/109.5.805</pub-id><pub-id pub-id-type="pmid">3779371</pub-id></citation></ref>
<ref id="B155"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winkler</surname> <given-names>C.</given-names></name> <name><surname>Sauer</surname> <given-names>H.</given-names></name> <name><surname>Lee</surname> <given-names>C. S.</given-names></name> <name><surname>Bj&#x000F6;rklund</surname> <given-names>A.</given-names></name></person-group> (<year>1996</year>). <article-title>Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson&#x02019;s disease</article-title>. <source>J. Neurosci.</source> <volume>16</volume>, <fpage>7206</fpage>&#x02013;<lpage>7215</lpage>. <pub-id pub-id-type="pmid">8929429</pub-id></citation></ref>
<ref id="B156"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woodlee</surname> <given-names>M. T.</given-names></name> <name><surname>Kane</surname> <given-names>J. R.</given-names></name> <name><surname>Chang</surname> <given-names>J.</given-names></name> <name><surname>Cormack</surname> <given-names>L. K.</given-names></name> <name><surname>Schallert</surname> <given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Enhanced function in the good forelimb of hemi-parkinson rats: compensatory adaptation for contralateral postural instability?</article-title> <source>Exp. Neurol.</source> <volume>211</volume>, <fpage>511</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2008.02.024</pub-id><pub-id pub-id-type="pmid">18417125</pub-id></citation></ref>
<ref id="B158"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wree</surname> <given-names>A.</given-names></name> <name><surname>Mix</surname> <given-names>E.</given-names></name> <name><surname>Hawlitschka</surname> <given-names>A.</given-names></name> <name><surname>Antipova</surname> <given-names>V.</given-names></name> <name><surname>Witt</surname> <given-names>M.</given-names></name> <name><surname>Schmitt</surname> <given-names>O.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson&#x02019;s disease</article-title>. <source>Neurobiol. Dis.</source> <volume>41</volume>, <fpage>291</fpage>&#x02013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2010.09.017</pub-id><pub-id pub-id-type="pmid">20955797</pub-id></citation></ref>
<ref id="B157"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Wree</surname> <given-names>A.</given-names></name> <name><surname>Schmitt</surname> <given-names>O.</given-names></name></person-group> (<year>2015</year>). &#x0201C;<article-title>Basal ganglia</article-title>,&#x0201D; in <source>Brain Mapping</source>, ed. <person-group person-group-type="editor"><name><surname>Toga</surname> <given-names>A. W.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier Academic</publisher-name>), <fpage>217</fpage>&#x02013;<lpage>227</lpage>.</citation></ref>
<ref id="B159"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ximenes</surname> <given-names>J. C. M.</given-names></name> <name><surname>Neves</surname> <given-names>K. R. T.</given-names></name> <name><surname>Leal</surname> <given-names>L. K. A. M.</given-names></name> <name><surname>do Carmo</surname> <given-names>M. R. S.</given-names></name> <name><surname>Brito</surname> <given-names>G. A.</given-names></name> <name><surname>Naffah-Mazzacoratti Mda</surname> <given-names>G.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Valproic acid neuroprotection in the 6-OHDA model of Parkinson&#x02019;s disease is possibly related to its anti-inflammatory and HDAC inhibitory properties</article-title>. <source>J. Neurodegener. Dis.</source> <volume>2015</volume>:<fpage>313702</fpage>. <pub-id pub-id-type="doi">10.1155/2015/313702</pub-id><pub-id pub-id-type="pmid">26317011</pub-id></citation></ref>
<ref id="B160"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zetterstr&#x000F6;m</surname> <given-names>T.</given-names></name> <name><surname>Herrera-Marschitz</surname> <given-names>M.</given-names></name> <name><surname>Ungerstedt</surname> <given-names>U.</given-names></name></person-group> (<year>1986</year>). <article-title>Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis</article-title>. <source>Brain Res.</source> <volume>376</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(86)90893-0</pub-id><pub-id pub-id-type="pmid">3087581</pub-id></citation></ref>
</ref-list>
</back>
</article>
